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Abstract
Human neural progenitor cells (hNPC) and human mesenchymal stromal cells (hMSC) have
both been reported to be able to promote improved functional recovery after grafting into ex-
perimental spinal cord injuries. Transplantation of pre-differentiated neural progenitor cells has
been shown to be an effective strategy to support repair of the spinal cord. In particular, the
implantation of astrocyte restricted precursors may represent a means of promoting spinal cord
recovery through the maintenance and support of axonal regeneration.
Although it has been demonstrated by our group that foetal hNPC, pre-differentiated to type I
astrocyte restricted precursors (hNP-AC), promote more extensive axon regeneration by adult
rat dorsal root ganglia (DRG) neurons in vitro than non-differentiated hNPC or hMSC, the
mechanisms of action to support neuritic outgrowth remained unclear. Therefore, hNPC were
characterised before and after in vitro differentiation to hNP-AC to provide a clearer definition
of the changes that the cells had undergone. Furthermore, possible contributions of released
trophic factors (i.e. present in conditioned culture medium) or substrate-mediated mechanisms
via the extracellular matrix (ECM) of hMSC and hNP-AC to support neuritic outgrowth were
investigated.
In the first part of this study, the in vitro immunocytochemical- and mRNA expression profile of
selected marker gens in hNPC and in the differentiated hNP-AC was quantified. Furthermore,
proliferative activity was estimated with a metabolic and a morphological assay, whereby the
latter, by measuring the increase in volume over time, provided an indirect indicator of prolifer-
ation within intact neurospheres. The hNPC grew as neurospheres, which were immunoreactive
for the stem/progenitor cell related markers nestin (91.0 ± 3.4%), SOX2 (89.2 ± 2.7%) as well
as musashi (91.8± 2.0%) and expressed CD133- and nestin mRNA. They showed spontaneous
differentiation capacity into MAP2ab+ and TuJ1+ neuronal phenotypes as well as S100β+ (17.6
i
± 2.1%), GFAP+ (23.7 ± 2.3%) and vimentin+ (96.8 ± 1.1%) astroglial precursors. Whereas
the differentiated hNP-AC demonstrated a similar immunocytochemical expression profile for
the stem/ progenitor cell related markers nestin (89.2 ± 3.8%), SOX2 (88.0 ± 3.6%), musashi
(89.2 ± 3.8%) and expressed CD133- and nestin mRNA in similar proportions to the hNPC,
the expression of astroglial markers increased. A significantly higher proportion of hNP-AC
were immunoreactive for S100β (79.4 ± 1.7%), GFAP (92.5 ± 3.4%) and CD44. Likewise,
hNP-AC demonstrated significantly increased CD44- and GFAP mRNA expression than the
non-differentiated hNPC. Estimation of proliferative activity of hNPC and hNP-AC showed a
reduced doubling time (DT ) in hNP-AC with a value of 5.1 days (morphological assay) and 3.2
days (metabolic assay), contrasting to hNPC prior to in vitro differentiation with a DT of 3.46
days (morphological assay) and 1.68 days (metabolic assay).
In the second part of this study, the contributions of trophic factors present in cell-conditioned
medium (produced by either hNP-AC or hMSC) and their ECM in supporting DRG axon regen-
eration were investigated in vitro. Conditioned media from both cell types strongly supported
neurite outgrowth over a defined PLL/laminin substrate. The ECM produced by the two cell
types, however, demonstrated contrasting effects: hNP-AC ECM promoted substantial axon re-
generation, but hMSC ECM supported relatively little axon growth. The combined application
of hNP-AC ECM and hMSC conditioned media induced the greatest degree of axon outgrowth.
The combination of hMSC ECM and hNP-AC conditioned medium, however, did not result in
any enhanced axon growth over the values determined using hMSC ECM and control growth
medium. Thus, although hNP-AC conditioned medium demonstrated potent trophic support for
DRG axon growth, its effect was not supported by signals derived from hMSC ECM. This raises
interesting questions for future experiments regarding the cross-talk between the intracellular
signalling cascades activated by diffusible trophic factors and those activated by ECM-related
molecules.
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Zusammenfassung
Humanen neuralen Vorla¨uferzellen (human neural progenitor cells, hNPC) und humanen me-
senchymalen Stromazellen (human mesenchymal stromal cells, hMSC) wird die Fa¨higkeit zuge-
schrieben funktionelle Genesung nach Transplantation in experimentell herbeigefu¨hrte Quer-
schnittsla¨hmung im Tiermodell zu fo¨rdern. Die Transplantation von pra¨-differenzierten neura-
len Vorla¨uferzellen hat sich als effektive Strategie zur Unterstu¨tzung der Wiederherstellung
nach experimentell herbeigefu¨hrte Querschnittsla¨hmung erwiesen. Insbesondere, die Implan-
tation von astrozyta¨ren Vorla¨ufern, ko¨nnte einen Weg zur Genesung von Querschnittsla¨hmung
mittels Aufrechterhaltung und Unterstu¨tzung der axonalen Regeneration darstellen.
Obwohl unsere Gruppe in vitro demonstrieren konnte, das fetale hNPC, die zu Typ I astro-
zyta¨ren Vorla¨ufern (human neural progenitor restricted Typ I astrocytes, hNP-AC) differenziert
wurden, gro¨ßere axonale Regeneration in Nervenzellen aus adulten Ratten Dorsal-/Spinalganglien
(dorsal root ganglia, DRG) begu¨nstigten als undifferenzierte hNPC oder hMSC, blieben die da-
zu fu¨hrenden Wirkmechanismen unklar. Daher wurden in der vorliegenden Arbeit die hNPC vor
und nach in vitro Differenzierung zu hNP-AC charakterisiert, um den vollzogenen zellula¨ren
Wandel eindeutiger zu bestimmen. Weiterhin, wurden mo¨gliche Beitra¨ge durch freigesetzte tro-
phische Faktoren (d.h. Faktoren, die in konditioniertem Kulturmedium anwesend sind) oder
substrat-vermittelte Mechanismen, via Extrazellula¨r Matrix (ECM) von hMSC and hNP-AC
untersucht.
Im ersten Teil dieser Untersuchung wurde das in vitro immunocytochemische- und das mRNA
Expressionsprofil von ausgewa¨hlten Markergenen in hNPC und differenzierten hNP-AC quanti-
fiziert. Weiterhin wurde die Proliferationsaktivita¨t mit einer metabolischen und einer morpholo-
gischen Untersuchung beurteilt, die mittels Vermessung der Volumenzunahme pro Zeiteinheit
einen indirekten Indikator der Proliferation in intakten Neurospheren darbot. Die hNPC ent-
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wickelten sich als Neurospheren, welche immunoreaktiv fu¨r die Stamm/Vorla¨uferzell verwand-
ten Marker Nestin (91,0 ± 3,4%), SOX2 (89,2 ± 2,7%) sowie Musashi (89,2 ± 3,8%) waren
und CD133- und Nestin mRNA exprimierten. Dabei wiesen die Zellen ein spontanes Diffe-
renzierungsvermo¨gen in MAP2ab+ und TuJ1+ neuronale Pha¨notypen sowie S100β+ (17,6 ±
2,1%), GFAP+ (23,7 ± 2,3%) und Vimentin+ (96,8 ± 1,1%) astrogliale Vorla¨uferzellen auf.
Wa¨hrend die differenzierten hNP-AC ein a¨hnliches immunocytochemisches Expressionsprofil
fu¨r die Stamm/Vorla¨uferzell verwandten Marker Nestin (89,2 ± 3,8%), SOX2 (88,0 ± 3,6%)
sowie Musashi (89,2 ± 3,8%) wie die hNPC aufwiesen und CD133- und Nestin mRNA in
a¨hnlichem Verha¨ltnis exprimierten, konnte ein Anstieg der Expression von astroglialen Mar-
kern beobachtet werden. Dies zeigte sich durch einen signifikanten Anstieg der Immunoreak-
tivita¨t fu¨r S100β (79,4 ± 1,7%), GFAP (92,5 ± 3,4%) und CD44 in hNP-AC. Ebenso wurde
in den hNP-AC ein signifikanter Anstieg der CD44- und GFAP mRNA Expression gegenu¨ber
den nicht-differenzierten hNPC nachgewiesen. Eine Bestimmung der Proliferationsaktivita¨t von
hNPC und hNP-AC ergab eine reduzierte Verdopplungszeit (doubling time, DT ) in hNP-AC
mit einem Wert von 5,1 Tagen (morphologische Untersuchung) und 3,2 Tagen (metabolische
Untersuchung), im Gegensatz zu den hNPC vor der in vitro Differenzierung mit einer Verdopp-
lungszeit von 3,5 Tagen (morphologische Untersuchung) und 1,7 Tagen (metabolische Unter-
suchung).
Im zweiten Teil dieser Arbeit wurden in vitro die Beitra¨ge von trophischen Faktoren der hNP-
AC bzw. der hMSC, welche in das Zellkulturmedium abgegeben wurden, sowie deren ECM im
Hinblick auf die Unterstu¨tzung der axonalen Regeneration von DRG untersucht. Das konditio-
nierte Medium beider Zelltypen induzierte einen weitreichenden, komplexen Neuritenauswuchs
der DRG, wenn diese auf ein definiertes PLL/laminin Kontrollsubstrat platziert wurden. Aller-
dings zeigte die ECM der beiden untersuchten Zelltypen einen entgegengesetzten Effekt: Die
hNP-AC ECM begu¨nstigte eine betra¨chtliche axonale Regeneration, wohingegen die hMSC
ECM einen signifikant geringeren axonalen Auswuchs induzierte. Die kombinierte Anwen-
dung von hNP-AC ECM und konditionierten hMSC Medium induzierte das gro¨ßte beobachtete
Neuritenwachstum. Die Kombination von hMSC ECM und konditionierten hNP-AC Medium
zeigte jedoch kein vergro¨ßertes axonales Wachstum im Vergleich zu den Werten, die mit hMSC
ECM und Kontrollkulturmedium erzielt wurden. Obwohl das konditionierte hNP-AC Medi-
um mit seinen potenten trophischen Faktoren das axonale Wachstum von DRG fo¨rderte, war
dieser Effekt nicht durch hMSC ECM bedingte Signale unterstu¨tzt. Hieraus resultieren interes-
sante Fragestellungen fu¨r zuku¨nftige Experimente zur genaueren Erforschung der Interaktion
zwischen intrazellula¨ren Signalkaskaden entweder aktiviert durch diffusionsfa¨hige trophische
Faktoren oder durch Wechselwirkungen mit ECM Moleku¨len.
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1 Introduction
1.1 Central Nervous System Injury
The inability of the central nervous system (CNS) to regenerate after injury has been one of
the most challenging neuroscientific themes for decades. While lesioned axons in the peripher-
al nervous system (PNS) may undergo successful regeneration leading to the reinnervation of
their targets (Guth, 1956; Hall, 1989; Stoll et al., 2002), damaged axons in the CNS regenerate
less well, if at all (Cajal, 1928; Clemente, 1964; Franklin and Blakemore, 1990).
The earliest documentation of many of the key symptoms of individuals suffering paralysis due
to spinal cord injury (SCI) is provided in the ancient Egyptian Edwin Smith papyrus from 1650-
1550 B.C. (Breasted, 1930; Hughes, 1988). It has been suggested that the author was Imhotep
(Anderberg et al., 2007; Donovan, 2007), whose advice that the condition was untreatable was
followed down through the ensuing millennia. The lack of axonal regeneration in the adult
mammalian CNS was accepted as ”law of nature”. Thus, brain and spinal cord lesions were
considered irreversible.
In the early 20th century, Santiago Ramon y Cajal was the first to describe that damaged CNS
axons are able to form sprouts, but that they did not extend for more than 1-2mm (Cajal, 1928).
Since then, numerous scientific and medical studies have challenged the previous dogma of the
irreversibility of CNS injury and dedicated their interest to better understand the cellular and
molecular basis for abortive sprouting in the damaged CNS, the ultimate goal being the mani-
pulation of these mechanisms to allow functional tissue repair following injury or disease.
The most important contributions have been published over the last 20-30 years. It has become
evident that the CNS does, indeed, have the capacity to regenerate. However, this capacity
is only transient and fails within a few days due to the development of a reactive growth in-
hibitory microenvironment around the axonal sprouts (Schwab and Bartholdi, 1996; Dumont
et al., 2002). The discovery of many pathophysiological events that take place after SCI has
resulted in the development of numerous highly innovative intervention strategies that were in-
tended to enhance functional recovery after CNS injury. Nevertheless, there is still a paucity
of clinically effective strategies for the treatment of severe CNS trauma such as SCI. Some of
the major pathophysiological events following SCI and a number of corresponding treatment
strategies will be highlighted in the following section.
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1.2 Mechanisms Influencing Axon Regeneration in the CNS
Whereas the developing mammalian nervous system is endowed with a large capacity of plas-
ticity, including the ability to regenerate, the potential for such adaptive behaviour decreases
with increasing age, particularly in the adult CNS (Singer et al., 1979; Shewan et al., 1995;
Bandtlow and Lo¨schinger, 1997; Martin et al., 2000).
There are three main impediments to axon regeneration and functional recovery following CNS
injury: namely the expression of potent axon growth inhibitory myelin associated proteins, the
formation of a glial scar by reactive astrocytes and cell death (Beattie et al., 2000; Jones et al.,
2001; Liu et al., 2006). The detrimental effects of these three processes are compounded by the
formation of fluid filled cysts or cavities at the lesion epicentre.
1.2.1 Inhibition of Axonal Regeneration by Myelin Associated Proteins
Oligodendrocytes and degenerating myelin were discovered to be potent inhibitors of axon re-
generation in the late 1980’s (Schwab and Thoenen, 1985; Savio and Schwab, 1990). Much of
the inhibitory effect of CNS myelin could be found in a protein fraction termed NI-220/250. The
development and application of the antibody, IN-1, which blocked the activity of NI-220/250,
resulted in a boosting of the extent of axonal growth over oligodendrocytes or CNS myelin in
vitro (Caroni and Schwab, 1988; Caroni et al., 1988) and in vivo (Schnell and Schwab, 1990;
Schwab, 2002). A decade later, the NI-220/250 antigen (named Nogo) was cloned indepen-
dently by three groups (Chen et al., 2000b; GrandPre´ et al., 2000; Prinjha et al., 2000), with the
isoform Nogo-A being identified as a major inhibitor to CNS regeneration (Pot et al., 2002).
Furthermore, other myelin associated proteins have been demonstrated to have potent axon
growth inhibitory effects, i.e. myelin-associated glycoprotein (MAG) and oligodendrocyte
myelin glycoprotein (OMgp; McKerracher et al., 1994; Mukhopadhyay et al., 1994; Wang et al.,
2002). However, it seems that MAG plays no significant role in the inhibition of CNS axons in
vivo (Bartsch et al., 1995; Li et al., 1996) and is lost or degraded very early after SCI (Buss and
Schwab, 2003).
These discoveries and the identification of the receptors responsible for mediating the inhibitory
effects of the myelin associated molecules have been the subject of numerous in vitro and in vivo
studies (McGee and Strittmatter, 2003; Xie and Zheng, 2008).
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1.2.2 The Astroglial Scar
Astrocytes are the key component of reactive gliosis (Eng et al., 1987) leading to the devel-
opment of a scar tissue, similar to the process observed in other organs following injury as a
protective and thereby beneficial reaction of the organism. However, the formation of an as-
troglial scar represents a major mechanical and molecular barrier to axonal regeneration (Hat-
ten et al., 1991; Freire et al., 2004; Yiu and He, 2006). In lesions that spare the dura mater,
the scar is composed primarily of astrocytes, but in more severe lesions, which open or rupture
the meninges, invading connective tissue elements and Schwann cells mix with the reactive as-
trocytes (Shuman et al., 1997; Pe´rez-Bouza et al., 1998; Brook et al., 2000; Silver and Miller,
2004).
A prominent hallmark of reactive gliosis is hypertrophy of the astrocytic cell body and pro-
cesses with increased production of intermediate filaments, such as glial fibrillary acidic protein
(GFAP; Barrett et al., 1981; Eng, 1985), renewed expression of vimentin (Dahl et al., 1981a,b;
Lin and Cai, 2004; Wilhelmsson et al., 2004) and nestin (Clarke et al., 1994; Frise´n et al., 1995;
Brook et al., 1999).
In the early 1990s, reactive astrocytosis was shown to be associated with the expression of axon-
repulsive extracellular matrix (ECM) molecules such as tenascin and four classes of proteogly-
cans (Snow et al., 1990; Katoh-Semba et al., 1995; McKeon et al., 1999; Jones et al., 2003a;
Tang et al., 2003) including the large family of chondroitin sulphate proteoglycans (CSPG)
with aggrecan, brevican, neurocan, neuronglial antigen 2 (NG2), phosphocan and versican
(Grimpe and Silver, 2002; Morgenstern et al., 2002). This led to the suggestion that certain
ECM molecules in the area of the lesion site played a major role in the failure of CNS axon
regeneration.
Nevertheless, axon growth-supportive molecules are also expressed by reactive astrocytes, for
example the ECM molecules laminin and fibronectin as well as poly-sialated neural cell adhe-
sion molecule (PSA-NCAM; Snow et al., 1996; Ridet et al., 1997; Silver and Miller, 2004; Gris
et al., 2007; Tate et al., 2007). The interactions of these and other axon growth repulsive and
growth promoting molecules results in an environment which provides either an overall sup-
port or inhibition of axon growth (Dou and Levine, 1995; Snow et al., 1996; Hynds and Snow,
2001).
Inflammatory cytokines such as interferon γ (IFNγ) and basic fibroblast growth factor (FGF-2,
bFGF) seem to contribute to the development of the glial scar (Yong et al., 1991; Mocchetti
et al., 1996). Furthermore, trophic factors such as the transforming growth factor β (TGFβ )
have been reported to be potential trigger molecules for inhibitory gliosis inducing an up-
regulation of the proteoglycan expression in astrocytes (Asher et al., 2000; Moon and Fawcett,
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2001). The elevated levels of TGFβ -1 expression immediately after injury suggest a role in the
acute inflammatory response and initiation of glial scar formation, whereas the later peak of
TGFβ -2 expression may be associated with subsequent tissue repair processes (Lagord et al.,
2002; Buss et al., 2008).
1.3 Cell-Transplantation Strategies to Enhance CNS Repair
The generation of an axon-growth promoting environment that is capable of bridging the cystic
cavities and the developing scar tissue of the lesioned CNS has been extensively studied dur-
ing the last three decades. Numerous strategies have been developed to promote CNS repair
following SCI, which particularly focus on the transplantation of a variety of cell types, often
in combination with other strategies: Cell-based repair strategies for promoting axon regenera-
tion across spinal cord lesions have included grafting of CNS- or PNS glia into the lesion site.
Transplantation of Schwann cells and/or olfactory ensheathing cells (OEC) provided promis-
ing results (Ramo´n-Cueto and Nieto-Sampedro, 1994; Ramo´n-Cueto et al., 1998, 2000; Sasaki
et al., 2007; Oudega, 2007; Bunge, 2008).
Furthermore the combination of cell transplantation strategies with the delivery of neurotrophic
factors (Jones et al., 2001; Bregman et al., 2002; Bunge, 2008) as treatment to override or
degrade the glial scar, as well as the combination with structurally engineered biomaterials
bridging the lesion for regenerating axons (Willerth and Sakiyama-Elbert, 2007) has promoted
functional improvement in experimental CNS injury models.
More recently, the potential of stem/progenitor cell based strategies has become apparent. Nu-
merous groups describe the benefits of stem/progenitor-cell based intervention strategies in pro-
moting functional tissue repair following either CNS- or PNS injury (Enzmann et al., 2005;
Someya et al., 2008; Eftekharpour et al., 2008; Bareyre, 2008; Willerth and Sakiyama-Elbert,
2008).
In this study main emphasis was laid on investigating the potential benefits of employing non-
neural human mesenchymal stromal cells as well as astrocytic precursors derived from human
foetal neural progenitor cells.
1.3.1 Human Mesenchymal Stromal Cells
Human mesenchymal stromal cells (hMSC) are non-neural cells isolated from bone marrow,
adipose or other tissues. These cells are able to adhere to plastic culture plates and display a
multi-potent differentiation capacity to osteoblasts, chondroblasts, adipocytes and myoblasts in
6
1.3 Cell-Transplantation Strategies to Enhance CNS Repair
vitro (Prockop, 1997).
Ten years ago, Azizi and colleagues reported the survival and migration of hMSC that had been
implanted in rat brains (Azizi et al., 1998). Since then, several groups have reported significant
functional improvement after grafting these cells into animal models of SCI (Wu et al., 2003;
Ohta et al., 2004; Li et al., 2005; Neuhuber et al., 2005; Himes et al., 2006).
However, the mechanism(s) of action by which grafted hMSC promote their beneficial effects
in experimental SCI is still poorly understood and remains controversial. There is no consensus
of opinion as to whether the reported transdifferentiation hMSC to neural cells contributes to
recovery (Chen et al., 2000a; Hofstetter et al., 2002; Li et al., 2005; Montzka et al., 2009; Va-
quero and Zurita, 2009).
Instead of serving as a cell replacement therapy, it is more likely that transplanted MSC affect
SCI repair by the following mechanisms: hMSC can act as ”feeder cells” supporting adjacent
neurons and glia by the production of cytokines, growth- and neurotrophic factors including
brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), nerve
growth factor (NGF), neurotrophin-3 (NT-3), interleukin 6 (IL-6), monocyte chemoattractant
protein (MCP), stem cell factor (SCF) and stromal cell-derived factor 1 (SDF-1) (Cheng et al.,
2003; Wu et al., 2003; Neuhuber et al., 2005; Shimode et al., 2007; Wagner et al., 2008).
Furthermore, it has been shown that MSC can provide an extensive ECM in vitro, consisting of
collagen I, collagen IV, fibronectin and laminin (Grayson et al., 2004), that might represent a
favourable substrate for axonal growth and contribute to the proliferation of endogenous CNS
progenitor cells (Deans and Moseley, 2000; Neuhuber et al., 2005; Parr et al., 2007).
For a better understanding of the potential beneficial effects of hMSC in repair strategies for
SCI, we have studied their direct effects on axon regeneration in vitro (Fu¨hrmann et al., 2010b).
Dissociated adult rat dorsal root ganglia (DRG) were plated onto semi-confluent hMSC mono-
layers and the extent of axon growth over a period of 24h was investigated. The study revealed
substantial cell-substrate interactions between the regenerating DRG axons and the underlying
hMSC monolayer. Viable hMSC were responsible for imparting a significant degree of di-
rectionality of axonal regrowth. Although the investigation confirmed the beneficial effect of
hMSC on neurite regeneration, the mechanism of this effect still remained unclear.
1.3.2 Human Neural Progenitor Cells
Human neural progenitor cells (hNPC), are proliferative cells from CNS tissue with restricted
self-renewal. Unlike stem cells, their ability to asymmetrically divide and to produce progeny
indistinguishable from themselves is limited (Svendsen et al., 1999; Seaberg and van der Kooy,
2003; Sohur et al., 2006). A cardinal feature of hNPC is their multi-potency, being able to
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differentiate into the three lineages of the CNS (i.e. oligodendroglial, astroglial and neuronal;
McKay, 1997; Gage, 2000; Sohur et al., 2006).
Because of the current lack of markers to clearly distinguish CNS stem cells from progenitor
cells (Uchida et al., 2000; Steindler and Laywell, 2003) the cells are usually characterised retro-
spectively on the basis of their behaviour after isolation in vitro (Carpenter et al., 1999; Weible
and Chan-Ling, 2007). However, prospective attempts to characterise neural stem- and progen-
itor cells have been attempted (Maric and Barker, 2004).
The hNPC may be obtained from embryonic (Thomson et al., 1998; Klimanskaya et al., 2006)
and foetal tissues (Svendsen et al., 1999; Uchida et al., 2000), as well as neurogenic regions in
the adult CNS where hNPC continue to reside (Goldman, 2005; Sohur et al., 2006). Even post
mortem CNS tissue has been suggested to be a source for hNPC (Schwartz et al., 2003).
Since the developing brain exhibits a high degree of plasticity, and can undergo regenerative
axonal regrowth (Nicholls and Saunders, 1996; Kalia, 2008) special attention has been laid on
the reparative potential effectiveness of neural stem/progenitor cells from embryonic (Wictorin
and Bjo¨rklund, 1992; McDonald et al., 1999; Davies et al., 2006) and foetal sources (Ogawa
et al., 2002; Tarasenko et al., 2007; Ogawa et al., 2009) for therapeutical approaches in SCI.
For effective transplantation studies, large volumes of cells are essential (Bjo¨rklund, 1993;
Svendsen et al., 1999; Kanemura et al., 2002). However, ethical concerns surrounding the use
of embryo- or foetus-derived cells, as well as the limited supply of donor tissues have strength-
ened the need and search for alternative sources of large numbers of donor cells.
Another important consideration in the use of hNPC for future clinical purposes is the clear
establishment of the parameters for culturing the cells, for example how long or for how many
passages can such cells be maintained in culture without loosing proliferative and differentiation
characteristics (Kanemura et al., 2002; Wachs et al., 2003; Herszfeld et al., 2006; Zeng, 2007).
Stem/progenitor cells isolated from embryonic tissues have been reported to possess properties
that are similar to those of cancer cells, such as genetic instability (Ignatova et al., 2002; Her-
szfeld et al., 2006) and lack of senescence (Tsai and McKay, 2002; Zeng, 2007), leading to the
transformation and tumorigenesis of the donor cells following grafting into the host Zheng et al.
(2002). The use of hNPC isolated from foetal tissues attenuates the risk of oncogenic transfor-
mation, especially when they have undergone differentiation prior to transplantation (Keirstead
et al., 2005).
Foetal hNPC have been transplanted into mice (Cummings et al., 2005; Ogawa et al., 2009), rat
(Wu et al., 2002; Watanabe et al., 2004; Liang et al., 2006; Tarasenko et al., 2007) and monkey
(Iwanami et al., 2005) SCI models. Spontaneous differentiation of donor foetal hNPC to glial
and neuronal phenotypes after transplantation has been reported (Snyder et al., 1997; Watanabe
et al., 2004; Liang et al., 2006; Tarasenko et al., 2007; Ogawa et al., 2009) and these have been
8
1.3 Cell-Transplantation Strategies to Enhance CNS Repair
described to contribute to tissue repair at the lesion site. However, the majority of donor hNPC
often fail to spontaneously differentiate into the desired cell types or differentiate at all, when
grafted into non-neurogenic areas of the adult CNS (Nicholls and Saunders, 1996; Schultz,
2005; Davies et al., 2006). To overcome this impediment, epigenetic modulation of hNPC prior
to transplantation has become popular. The transplantation of oligodendroglia, derived from
differentiated hNPC has been shown to promote remyelination and improvement in locomotor
function after SCI (Keirstead et al., 2005; Nistor et al., 2005; Faulkner and Keirstead, 2005).
Following a similiar logic, the transplantation of astrocytes derived from foetal hNPC might
represent an attractive cell type to support SCI repair.
1.3.3 Differentiation of Foetal hNPC to Astrocyte Restricted Precursors
At first glance, the beneficial effects of implanting astrocytes into the lesioned CNS might seem
counter-intuitive, since reactive astrocytes represent the major component of the axon growth
inhibitory glial scar (see section 1.2.2). However, the developmental stage of astroglia influ-
ences their ability to form scar tissue and the balance of their axon growth-inhibiting versus
growth-promoting properties (Barrett et al., 1984; Silver and Miller, 2004). Their re-expression
of developmental markers is suggestive of a phenotypic shift to a morphology that is support-
ive to regeneration. Indeed, cocultures of neurons and vimentin+/nestin+/GFAP+-astrocytes
exhibit increased axonal growth, suggesting that this phenotype is one that encourages regener-
ation (Menet et al., 2000).
The first indications of the beneficial effects of immature astroglia in CNS injury were reported
in the 1980s; astrocytes from the developing brain were suggested to be an ideal substrate for
neuron regeneration in vitro (Noble et al., 1984; Fallon, 1985a,b; Tomaselli et al., 1986, 1988;
Fawcett et al., 1989) and in vivo (Silver and Ogawa, 1983; Smith et al., 1986, 1990; Silver,
1988). Since then, numerous studies have suggested that young or immature astrocytes may
provide a favourable substrate for axon regeneration following SCI (Fawcett et al., 1992; Biran
et al., 2003; Tom et al., 2004; Davies et al., 2006).
In order to generate immature astrocytes for the repair of experimental CNS injuries, a tech-
nique for the rapid generation of a large, homogenous population of astrocytic cells has been
developed: in vitro epigenetical differentiation of hNPC to human neural progenitor derived
type I astrocyte restricted precursors (hNP-AC) by supplementing tissue culture medium with
bone morphogenetic protein 4 (BMP4; Gross et al., 1996; Mehler et al., 1997, 2000; Zhang and
Li, 2005) and leukemia inhibitory factor (LIF; Bonaguidi et al., 2005; Nakashima et al., 1999)
encourages the generation of astrocyte restricted progenitors (Weible and Chan-Ling, 2007).
Rat embryonic neural precursors have been used to generate astrocyte restricted precursors for
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transplantation into experimental SCI and have promoted locomotor recovery, axon regrowth
and the suppression of scar formation, in contrast to transplanted undifferentiated precursors
(Davies et al., 2006). However, differentiation and grafting of type II astrocytes was reported to
induce allodynia (Hofstetter et al., 2005). This observation was supported by Davies and col-
leagues who compared the effects of implanting type I and type II astrocytes into experimental
SCI; type I astrocytes encouraged robust axon regeneration whereas type II astrocytes increased
allodynia-like symptoms (Davies et al., 2008).
Recent studies performed in our research group have demonstrated that monolayers of foetal
hNP-AC support significantly stronger DRG neurite outgrowth than non-differentiated hNPC
or hMSC in vitro (Fu¨hrmann et al., 2010a,b). It might be possible that the neural progenitor
cell derived type I astrocytes secreted benefical substances into the culture media thereby sup-
porting outgrowth of regenerating DRG neurites: it has been reported that astrocytes produce
neurotrophic factors, such as BDNF (Ikeda et al., 2001), ciliary neurotrophic factor (CNTF; Lee
et al., 1998), NGF (Krenz and Weaver, 2000), FGF-2 (do Carmo Cunha et al., 2007) and the
neurogenic factors Neurogenesin-1 and Neuregulin 1 (Liberto et al., 2004; Ueki et al., 2003;
Barkho et al., 2006).
In addition to diffusible factors, ECM-associated mechanisms contribute importantly to control
axon growth in CNS development and after injury (Zhou and Snider, 2006). Although reactive
astrocytes produce CSPGs, molecules that are inhibitory to neurite growth (see section 1.2.2),
they also produce ECM molecules that are supportive to axon growth: especially, the ECM
substrate generated by immature astrocytes has been reported to regulate cell adhesion, mi-
gration, morphogenesis as well as supporting neurite outgrowth (Powell et al., 1997; Pindzola
et al., 1993; Kiryushko et al., 2004; Freire et al., 2004) via the presence of neural cell adhesion
molecules (NCAM; Noble et al., 1985; Smith et al., 1993) with N-Cadherin (Tomaselli et al.,
1988), laminin (Liesi et al., 1984; Liesi and Silver, 1988; Smith et al., 1993; Freire et al., 2004)
and fibronectin (Tom et al., 2004). Several studies clearly demonstrated that in vitro derived
astrocytes presented associated laminin matrices enabling neurite regeneration (Garcia-Abreu
et al., 1995; Martinez and Gomes, 2002).
Finally, increasing evidence is emerging that theses influences contribute to enhance neurite
regeneration and outgrowth via an intra- and intercellular cross-talk, that is coordinated by
interactions of diffusible secreted factors and ECM-mediated mechanisms (Zhou and Snider,
2006).
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Although neural and non-neural stem/progenitor cell transplantation strategies have shown pro-
mising results as a therapeutical approach for SCI, the mechanisms of action remain poorly
defined (Okano et al., 2003; Iwanami et al., 2005; Enzmann et al., 2005; Garbuzova-Davis
et al., 2006; Oudega, 2007; Eftekharpour et al., 2008; Kitada and Dezawa, 2008).
In an attempt to better understand the beneficial interactions of stem/progenitor cells with re-
generating neurites our group has studied the axon growth promoting effects of hMSC-, hNPC
and hNP-AC monolayers in vitro with dissociated DRG neurons as model of repair after CNS
injury (Fu¨hrmann et al., 2010a,b). We could show that hNP-AC promoted stronger outgrowth
than either non-differentiated hNPC or hMSC. Furthermore, hMSC were able to direct neurite
regeneration.
1.4.1 Part I
Characterisation and Proliferative Activity of hNPC and hNP-AC
The following questions were addressed:
I) To what extent has the in vitro differentiation process of hNPC altered the cellular char-
acteristics in hNP-AC?
II) Does the differentiation of hNPC to hNP-AC alter their proliferative activity?
Cell therapy strategies with hNP-AC in SCI would require substantial numbers of homoge-
neous, well defined populations of cells. Therefore, it was of interest to characterise the cell
population of hNPC before and after differentiation in vitro and to investigate their proliferative
activity.
For this purpose, immunocytochemistry and reverse transcription polymerase chain reaction
(RT-PCR) were used to identify changes in the expression of stem/progenitor- and astrocyte-
related markers. A metabolic and a morphological assay were used to assess proliferation.
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1.4.2 Part II
Effects of Released Factors and ECM on Neurite Regeneration in Vitro
The mechanisms by which hMSC and hNP-AC supported neurite regeneration remained un-
clear. Therefore, the possible contributions of released trophic factors (i.e. present in con-
ditioned medium) or substrate-mediated mechanisms (via the ECM) were investigated. The
following hypotheses were tested and will be addressed in Part II of this thesis:
I) Both, diffusible trophic factors (i.e. present in conditioned medium) and ECM-related
mechanisms contribute to hNP-AC- and hMSC-mediated support of axonal regeneration.
II) To what extent can the neuronal responses to diffusible trophic factors (i.e. present in
conditioned medium) be modified by interactions with its environment (i.e. the ECM)?
Similarly, to what extent are the responses of the cell to its ECM environment modified
by the presence of diffusible trophic factors?
Morphological studies were used to determine to what extent cellular components (i.e condi-
tioned medium and ECM) of hMSC or hNP-AC might influence neurite regeneration. A com-
binatory application of cellular components of hMSC and hNP-AC was used to investigate their
interactions and possible effects on regenerating neurites.
It is anticipated that such information may contribute to the optimisation of future in vivo inter-
vention strategies intended to promote functional repair following traumatic injury to the CNS.
The study was performed with adult rat DRG neurons as an in vitro model for axon regenera-
tion. Varying parameters were the ECM substrate deposited by either hMSC or hNP-AC and
their trophic factors, which had been released into the applied culture media before.
1.4.3 Main Findings
In Part I of this thesis it will be shown that the hNPC represent a multipotent and heteroge-
nous population of neural progenitor cells possessing the capacity to spontaneously differenti-
ate into neuronal or astroglial phenotypes. Differentiated hNP-AC demonstrated a significant
up-regulation of typical astroglial markers, whereas the expression of stem/progenitor-related
markers remained constant. However, the rate of proliferation of hNP-AC was reduced when
compared to that of non-differentiated hNPC.
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In Part II of this thesis it will be shown that the ECM of hNP-AC strongly promoted neurite out-
growth in vitro, whereas the ECM of hMSC promoted less robust outgrowth. Produced trophic
factors released into the culture media from both stem/progenitor cell types strongly supported
the outgrowth in regenerating neurites. The combination of hNP-AC derived ECM with hMSC
derived trophic factors interacted in a benefical manner, thereby potentiating neurite outgrowth
promotion in regenerating DRG.
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Part I
In Vitro Characterisation and Proliferative
Activity of hNPC and hNP-AC

2 Material and Methods
2.1 Cell Culture
2.1.1 Cultivation of hNPC Neurospheres
The hNPC used in this study were derived from 16-week human foetal forebrain and propagated
by using the neurosphere technique. Neurospheres of human neural stem/progenitor cells are
aggregates of more than a thousand individual cells and contain heterogeneous populations of
neuronal, astroglial and oligodendroglial precursor cells (Reynolds and Weiss, 1996; Svendsen
et al., 1999). The hNPC were purchased from Lonza (formerly Cambrex Bioscience, Belgium)
and used according to all state and federal guidelines.
The neurospheres were cultivated in a humidified chamber at 37◦C with 5% CO2. To grow
hNPC as monolayers or as adherent neurospheres, tissue culture plastic was treated with ster-
ile poly-L-lysine (PLL, 0.01%, Sigma) for one hour, followed by two washing steps with
0.1M phosphate buffered saline (PBS) and the addition of the purified ECM molecule laminin
(5µg/ml, Roche) in 0.1M PBS overnight. The next day the PLL/laminin surface was rinsed
with medium (see below) and seeded with dissociated hNPC to form monolayers or with neu-
rospheres.
Neurospheres were grown in suspension culture for up to 6-8 months using serum-free neural
progenitor proliferation media (NPPM; Reynolds and Weiss, 1992, 1996; Svendsen et al., 1998,
1999). The medium contained:
Ham’s F-12 nutrient mixture + GlutaMAXTM (HAM F12, Invitrogen)
Dulbecco’s Modified Eagle’s Medium + GlutaMAXTM + 4.5g/liter D-Glucose and Pyru-
vate (DMEM, Invitrogen)
with a concentration of HAM F12/DMEM (1:1 vol/vol)
Human recombinant epidermal growth factor (EGF, 20ng/ml, Cell Concepts)
Human recombinant basic fibroblast growth factor (bFGF/ FGF-2, 20ng/ml, Invitrogen)
B27 supplement (1:50 vol/vol, Invitrogen) without retinoid acid
Penicillin/streptomycin (1:100 vol/vol, PAA)
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All components were sterile filtered (Millipore Stericap Plus, 0.22µm) and media was stored at
2-8◦C. Before application to spheres, media was warmed to room temperature. Neurospheres
were kept in T75 flasks (Greiner, Cellstar) and half of the medium was changed every other day.
2.1.2 Passaging of Neurospheres
Neurospheres were passaged every 7-10 days by incubation with Accutase (PAA, Innovative
Cell Technologies Inc.) as described earlier (Wachs et al., 2003). Briefly, culture medium
containing floating neurospheres was collected in a 15ml Falcon tube and centrifuged at 800
revolutions per minute (rpm) for 5 minutes. The cell pellet was resuspended in 200µl Accu-
tase (ready to use solution), triturated with a 200µl pipette 10-15 times and incubated for 10
minutes at 37◦C. Dissociated spheres were again triturated with a 200µl pipette 20-30 times to
remove persisting cell bridges. Single cells were resuspended in NPPM and plated in T75 cell
culture flasks with 10ml of fresh culture medium. The resultant single cell suspension formed
new spheres within 1-3 days and were named passage 1 (P1), passage 2 (P2),... with increasing
passage number after each Accutase treatment. Cells, that did not form new spheres after dis-
sociation or became adherent in higher passages, were removed from culture.
2.1.3 hNP-AC Differentiation
At P4-P8 NPPM was changed to neural progenitor differentiation media (NPDM) to generate
hNP-AC as described earlier (Weible and Chan-Ling, 2007). NPDM consisted of:
Neural basal media 1x (Invitrogen) mixed with
GlutaMAXTM 0.5mM (1:100 vol:vol, Invitrogen)
B27 Supplement (1:50 vol:vol, Invitrogen) without retinoid acid
Human recombinant EGF (20ng/ml, Invitrogen)
Human recombinant bFGF (20ng/ml, Invitrogen)
Leukemia inhibitory factor (LIF, 10ng/ml, Chemicon)
Bone morphogenetic protein 4 (BMP4, 20ng/ml, R&D Systems)
Penicillin/streptomycin (1:100 vol/vol, PAA)
Cells were seeded at a densitiy of 2.5 ·104cells/ml in T75 flasks and initially half of the media
was changed. The following day, media was changed completely to NPDM.
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Half of the medium was replenished every other day. After 1-2 weeks neurospheres were pas-
saged with Accutase and named PxP1, ..., PxP14 with increasing passage number after each
Accutase treatment. The first passage number (x) shows for how long the cells were kept in
an undifferentiated state with NPPM treatment before the differentiation treatment was started.
The second passage number represents the differentiation phase with NPDM treatment to gen-
erate hNP-AC.
2.1.4 Cryopreservation and Retrieval from Frozen Storage
For cryopreservation, neurospheres or single cell suspensions of hNPC or hNP-AC were treated
with the cryoprotective agent dimethyl sulfoxide (DMSO). Cryomedium consisting of 80%
medium, 10% foetal calf serum (FCS; PAA) and 10% DMSO (Sigma Aldrich) was sterile fil-
tered. Cryotubes (Nunc, Apogent) were loaded with 1.5ml cryomedium containing single cell
suspensions of approximately 4 ·106 cells and cooled down slowly at 1◦C/min to -80◦C being
placed in a freezing box (Roth) containing isopropyl alcohol. After 4-5 hours, the cryotubes
were transferred to liquid nitrogen for long term storage.
To retrieve cells from frozen storage, cryotubes were immersed in a warm water bath (37-40◦C)
for 3 minutes to transfer cells in a semi-thawed state. After centrifugation to remove DMSO,
cells were transferred rapidly to fresh culture medium and grown in PLL/laminin coated cell
culture flasks as monolayers. When grown to confluence after 1-2 weeks, cells were dissociated
using 2-3ml of Accutase (see section 2.1.2), transferred to non-coated cell culture flasks and
cultured as floating neurospheres by spontaneous aggregation. Cells that returned to the sub-
strate and grew as adherent cultures were excluded from the investigation.
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2.2 Immunocytochemistry
2.2.1 Slide Preparation
Immunocytochemistry was performed on:
I) cryosections of intact neurospheres,
II) intact neurospheres adherent on PLL/laminin coated coverslips and
III) single cells from dissociated neurospheres adherent on PLL/laminin coated coverslips.
Free floating neurospheres as well as coverslips with adherent neurospheres or single cells were
fixed for 1 hour in 4% paraformaldehyde (PFA) and washed three times in 0.1M PBS. To reduce
cryoartefacts, non-adherent intact neurospheres were transferred to a 30% sucrose solution in
0.1M PBS for 72 hours at 4◦C. Spheres were embedded in Tissue-Tec, frozen, cryosectioned
(with 8µm thickness of slices) at -22◦C and collected on objective slides (Superfrost Plus Gold,
Menzel). Sections were either immediately processed for immunocytochemistry or were stored
at -80◦C for later use.
2.2.2 Double Immunofluorescence
All antibodies were diluted in antibody diluent consisting of 0.1M PBS containing 1% bovine
serum albumin V (BSA, Serva). Sections were treated with antibody dilution (ABD) containing
1% Triton-X 100 and 3% normal goat serum followed by primary antibodies (see Table 2.1)
overnight at room temperature in a humid atmosphere. The next day, sections were washed 3
times in 0.1M PBS followed by incubation in secondary antibodies (dilution 1:500; see Table
2.1) conjugated to either Alexa 594 (Molecular Probes) or Alexa 488 (Molecular Probes) for 2.5
hours in the dark. A nuclear counterstain with diamidino-2-phenylindol (DAPI, 1µg/ml stock
solution, Molecular Probes) was added to the secondary antibody solution (dilution 1:1000).
Primary antibodies were omitted for the negative control slides. After 3 washing steps in PBS
the samples were coverslipped using Fluoroprep R© (BioMerieux, Nurtingen, Germany). Probes
were stored in the dark at 4◦C before viewing with an inverted epi-fluorescence microscope
(Leica, DMI 4000B).
2.2.3 Image Analysis of Immunofluorescence
Immunocytochemical analysis of hNPC was assessed on different passage numbers in culture
(P2, P3, P6, P7, P11). Immunocytochemical analysis of hNP-AC was performed, after dif-
ferentiation for at least 8 passages in NPDM according to Weible and colleagues (Weible and
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Chan-Ling, 2007). Immunofluorescence was used to quantify the phenotype of cells migrating
from neurospheres that had been seeded on to PLL/laminin coated surfaces over a period of 24
hours. This experimental approach allowed rapid adhesion of neurospheres and subsequent cell
migration, resulting in the formation of cellular monolayers.
Quantification of the different phenotypes was accomplished by counting at least five non-
overlapping, randomly chosen, microscopic fields (280µm x 212µm, magnification of 200x)
from three independent experiments. Each field contained between 50-200 cells. The total
number of cells within the fields were evaluated by counting the DAPI-positive nuclei. Then,
the ratio (%) of monoclonal- and polyclonal antibody immunoreactive cells to total number of
cells was calculated.
Neurosphere cryosections were used to investigate the spatial distribution of particular im-
munostained cells throughout the hNPC-spheres. In 8µm sections, the false indications of
double immunoreactivity were minimal since cells diameters ranged from 7-13µm.
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Table 2.1: Summary of antibodies used in this study
Antibody Source Dilution
Monoclonal Antibody
Anti-CD44 (Hermes antigen, HCAM) Sigma 1:200
Anti-vimentin Sigma 1:10000
Anti-nestin Chemicon 1:200
Anti-neurofilament, 200kD (NF200) Sigma 1:2000
Anti-microtubule-associated protein 2a+b (MAP2a+b) Sigma 1:500
Anti-tubulin β , isotype III (TuJ1) Sigma 1:400
Anti-O1 Chemicon 1:200
Anti-O4 Chemicon 1:200
Anti Galactocerebrosidase C (GalC) Chemicon 1:200
Polyclonal Antibody
Anti-GFAP Dako 1:2000
Anti-S100 beta (S100β ) Dako 1:2000
Anti-nestin Chemicon 1:500
Anti-Sox 2 (SOX2) Chemicon 1:2000
Anti-Musashi-1 Chemicon 1:400
Anti-Ki67 Chemicon 1:100
Secondary Antibody
Alexa fluor 488 goat anti-rabbit Molecular Probes 1:500
Alexa fluor 594 goat anti-mouse Molecular Probes 1:500
Nuclear Staining
Diamidino-2-phenylindol (DAPI) Molecular Probes 1:1000
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2.3.1 Isolation of mRNA
A molecular biological approach was employed to obtain a semi-quantitative estimation of ex-
pression profiles of hNPC and their derivate hNP-AC. The expression level of a range of mes-
senger ribonucleic acids (mRNA) was examined using reverse transcription PCR (RT-PCR) for
hNPC (up to P7) and for hNP-AC (up to P12; Table 2.2).
The mRNA was isolated and enriched using the RNeasy-Mini-Kit (Qiagen) according to the
manufacturers recommendations. To extract RNA from neurospheres of different passage num-
bers, 5 ·106 - 1 ·107 cells were harvested and centrifuged per sample. Cell pellets were stored
at -20◦C until isolation of RNA was performed.
Cell disruption and release of RNA was performed with the supplied lysis buffers (RLT R©,
600µl). β -mercapthoethanol (6µl) was added as a stabilizing agent to each probe. Homogeni-
sation of the lysed cells was carried out with a QIAshredder homogenizer to reduce viscosity of
the cell lysates. All working steps were performed with RNase free reagents and instruments.
The resulting lysate volume was then mixed with ethanol (70%, 600µl) and transferred to a
RNeasy mini spin column. Centrifugation was carried out at 10,000rpm for 15 seconds (sec).
The bound RNA in each column was washed with Buffer RW1 R© (700µl) and centrifuged at
10,000rpm for 15sec. Columns were washed twice with buffer RPE R© (500µl), and finally cen-
trifuged at 16,000rpm for 2 minutes to dry the columns. Then columns were transferred to new
1.5ml Eppendorf containers and RNA was eluted out of each column by addition of 30µl RNase
free water and centrifugation at 10,000rpm for 15sec. Isolated RNA was stored at -20◦C.
The concentration of RNA was measured using a thermo scientific spectrophotometer (Nano-
DropTM 1000). Absorbance of each sample was measured within 10 seconds up to a concen-
tration of 3700ng/µl.
To estimate quality and quantity of isolated RNA probes, the maximum of absorbance was used
at a wavelength of λ = 260nm. To determine pureness of the RNA probes the amount of protein
was also measured at a wavelength of λ = 280nm. Optical densiometry of RNase free water was
used as blank value in the measurement. Since RNA samples were diluted in RNase free water
a measurement in linear alignment could be assured. The ratio of absorbance at wavelength
260nm to wavelength 280nm (A260/A280) represents the degree of purity, which should be at
least 1.7. The degree of purity of samples used in this study all had a value of at least 1.95 (see
Table 2.2).
MCF-7 (a human mamma adenocarcinoma cell line), THP-1 (a human acute monocytic leukemia
cell line) and U373 (a human glioblastoma cell line) were processed as described above and
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used as positive controls for ongoing RT-PCR. H20 served as negative control. The housekeep-
ing gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as internal control.
Table 2.2: Summary of mRNA concentrations used in this study
mRNA Sample Ratio
A260/A280
Concentration
[ng/µl]
hNPC, culture passage (P)
P2 2.01 285.69
P3 2.00 119.7
P7 2.11 348.45
P7 2.02 461.58
hNP-AC, culture passage (P)
P4P5 2.03 224.81
P4P10 1.95 115.20
P8P4 2.01 215.94
P8P12 2.00 212.56
Positive Controls
U373 2.05 166.5
MCF-7 2.03 597.8
THP-1 2.07 253.3
Negative Control
mRNA free H2O - -
2.3.2 Synthesis of Complementary DNA
For transcription of isolated RNA into complementary deoxyribonucleic acid (cDNA) the Omni-
scriptTM Reverse Transcriptase Kit (Qiagen) was used. To amplify the genes of interest, in a
first step the mRNA was amplified by the reverse transcriptase enzyme. To accomplish reverse
transcription, a specific oligo-(dT)-primer (Fermentas) was utilised. The primer hybridizes at
the 3’-poly A-tale of the mRNA, allowing a complementary cDNA elongation of the mRNA
single strand. Furthermore a random primer (Fermentas) was used to improve a continuous
transcription. A mRNA-cDNA-hybrid was established, which was denatured with cDNA avail-
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able for subsequent PCR as a single strand template.
According to the protocol, template RNA (xµg), RT-buffer, oligo-dT-primer, random primer,
reverse transcriptase and RNase free water (11µl-x) were adjusted to an end volume of 20µl,
while being stored on ice. Reaction batches were composed as follows:
10x RT-buffer 2µl
Deoxyribonucleotide triphosphate (dNTP) -mix (5mM) 2µl
oligo-(dT)-primer (10pM/µl) 2µl
random primer (10nM/µl) 2µl
omniscript reverese transcriptase (4U/µl) 1µl
RNase free water 11µl-x
template RNA (ng/µl) xµg
total volume 20µl
Variable amounts of RNase free water were added, depending on the mRNA concentration (see
Table 2.2). Reverse transcription proceeded for one hour at 37◦C and was terminated by an
enzyme inactivation step of 95◦C for 5 minutes followed by a cooling step of 4◦C. The cDNA
products were either stored at -20◦C or used immediately for RT-PCR.
2.3.3 Polymerase Chain Reaction
Polymerase chain reaction (PCR) serves as a method for in vitro amplification of cDNA frag-
ments. Primer sequences for CD44 (Hermes antigen, HCAM) and CD133 (Prominin-1) were
generated with genome information from Ensembl Data. The other primers used in this study
relate to sequences described earlier (Montzka et al., 2009).
Table 2.3: Reaction cycle of PCR
reaction cycle temperature duration
denaturation 95◦C 60sec
annealing see TA (see Table 2.4) 60sec
extension/ elongation 72◦C 60sec
last elongation 72◦C 10min
cool 4◦C ∞
Each cycle was introduced by an initial denaturation step at 95◦C for 60sec to achieve a com-
plete separation of the double-stranded DNA. Primers annealed to the 5’ and 3’ end of the
sought-after cDNA sequence.
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Regulation of annealing temperature (TA), design of primer pairs and the composition of reac-
tion batch play an important role concerning sensitivity and specificity of the PCR and had to be
optimised for each PCR (see Table 2.4). The specific TA was adjusted to 60sec (see Table 2.3).
A thermo stable DNA-dependant polymerase attached to the double stranded sequence consist-
ing of primer and synthesised cDNA and started DNA-synthesis (72◦C for 60sec). The final
incubation at 72◦C for 10min terminated the cycle (see Table 2.3). The specific DNA sequences
of interest were exponentially amplified by repeating the cycles. The number of repetitions was
optimised for each PCR as well.
Amplification was performed with the synthesised cDNA, Ready Mix REDTaqTM PCR re-
action mix (Sigma), as well as appropriate sense- and antisense oligunucleotide primers (MWG
Biotech). Reaction batches were pipetted into a sterile RNase free PCR-tube (Biozym):
ready mix REDTaqTM 12.5µl
distilled water 6.5µl
forward primer (10 pmol) 2µl
reverse primer (10 pmol) 2µl
cDNA (5ng/µl) 2µl
total volume 25µl
Denaturation, annealing and synthesis were performed in a Thermocycler (Biometra), whereas
the temperature profiles of the PCR differed only in the specific annealing temperature of the
particular primer (see TA, Table 2.4). After termination of PCR, reaction products were either
stored at 4◦C or used directly for gel electrophoresis (agarose, 2%).
2.3.4 Agarose-Gel-Electrophoresis and Semi-Quantitative Analysis
Agarose (2%) was boiled in Tris-acetate-EDTA (TAE)-buffer (1x) and after cooling to 60◦C,
the suspension was poured into a gel-chamber. Ethidium-Bromide (EtBr; 0.05µg/ml, Roth) was
added to visualise the DNA fragments in UV-light. The hardened gel was transferred into an
electrophoresis apparatus (Subcell G, BioRad) and covered with TAE-buffer (1x). Samples of
a complete reaction batch were pipetted in gel-bags on the side of the cathode and separated at
120 volt. A PCR-1kb-ladder (Gene-RulerTM, 0.5µg/µl, MBI Fermentas) was used to estimate
the size of DNA fragments (see additional data, Fig. 9.1). Fluorescent DNA bands were visu-
alised with a digital camera (Gel Doc 2000, BioRad) and processed with MultiAnalyst software
1.1. The number of pixels associated with the images of each DNA band was analysed semi-
quantitatively with Image J 1.41o/Java 1.6.0-10 software and calculated as a ratio of the amount
of pixels detected in the internal control, GAPDH band. Samples to be compared were adjusted
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Table 2.4: Forward (FW)- and reverse (RV) primers for reverse transcription PCR
Gene Primer Sequence 5’-3’ bp TA r
GAPDH (FW) tga agg tcg gag tca acg gat ttg gt
983 62◦C 30
GAPDH (RV) cat gtg ggc cat gag gtc cac cac
S100β (FW) gga gac aag cac aag ctg aag
322 63◦C 30
S100β (RV) agc tac aac acg gct gga aag
GFAP (FW) gtg gta ccg ctc caa gtt tgc ag
373 59◦C 40
GFAP (RV) aat ggt gat ccg gtt ctc ctc
Nestin (FW) gcg ttg gaa cag agg ttg gag
385 65◦C 30
Nestin (RV) gca cag gtg tct caa ggg tag
Vimentin (FW) ccc tta aag gaa cca atg agt ccc tgg aac
301 64◦C 30
Vimentin (RV) gag tga atc cag att agt ttc cct cag gtt c
CD44 (FW) tgc ttc aat gct tca gct cc acct g
375 64◦C 33
CD44 (RV) tga ttc aga tcc atg agt ggt atg
CD133 (FW) cca agt tct acc tca tgt ttg g
527 60◦C 40
CD133 (RV) cca aca ggg aga ttg caa agc
Human specific forward (FW)- and reverse (RV) primers for reverse transcription PCR with annealing temperature
(TA), number of PCR cycles (r) and base pair length (bp) of amplification products.
to an equal strength of GAPDH band strength (see additional data, Fig. 9.1).
For statistical evaluation, analysis of variance (ANOVA) with Bonferroni’s post hoc Multiple
Comparison Test were performed using Graph Pad Prism software. The results are presented as
mean ± standard error of the mean (SEM) with p< 0.05 considered as significant.
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2.4 Proliferation of hNPC and hNP-AC
Two different methods were used to estimate the proliferation rate:
I) a metabolic assay in which metabolic activity was determined by a fluorescent signal
that was proportional to the number of viable cells in the sample;
II) a morphological assay, providing an indirect indicator of proliferation within intact
neurospheres by measuring the increase in volume over time.
2.4.1 Cell Titer Blue Metabolic Assay
As metabolic assay the cell viability assay Cell Titer Blue R© (Promega) was used. The Cell
Titer Blue R© reagent contains the indicator dye resazurin which, within the cytoplasm of vi-
able cells, is converted to the highly fluorescent metabolite resorufin. The fluorescent signal
correlates with the amount of resorufin produced and therefore represents the amount of living
cells (Fig. 2.1A). Proliferation of hNPC and hNP-AC was measured in monolayer cell cultures
adhering to a PLL/laminin substrate.
Cell Titer Blue R© reagent was added to cell culture medium at a ratio of 1:5 incubated with
the cells at 37◦C for two hours. Fluorescent samples were transferred to an opaque 96-well
plate for measurement. Fluorescence was measured with a fluoremeter (Fluostar Optima, BMG
Laptech) at an extinction of 560nm and an emission of 590nm.
Empty wells without cells served as negative (no-cell) controls to determine the background
fluorescence. Wells with untreated cells served as negative (vehicle) controls.
The average of fluorescence values of the culture medium controls (background) and the neg-
ative (no cell) controls were subtracted from all fluorescence values of experimental wells.
Optima software 2.20 (BMG Laptech) was used for acquisition of data.
A standard curve for the metabolic assay was generated to examine, whether the indirect mea-
surement of viable cells was accurate for both, hNPC and hNP-AC. For this purpose neuro-
spheres were dissociated and the number of cells was counted in a Neubauer chamber. Cell
suspension (1ml volume) was seeded on to PLL/laminin coated 12-well plates with an increas-
ing concentrations of cells (5 ·104 - 1.2 ·106 cells/ml) for calibration of fluorescence intensitiy.
The calibration curve was determined on the basis of the mean values from 5 independent ex-
periments. The standard curves revealed a significant linear relationship (r2 = 0.93 for hNPC
and r2 = 0.97 for hNP-AC) between 590nm emission and the number of cells (Fig. 2.1B).
The blank value with a fluorescence of 941 for hNPC and 875 for hNP-AC was substracted
from all data, so that a best-fit line with linear approach resulted for ongoing calculations. The
standard curves of hNPC and hNP-AC differed in their gradients with an overall higher fluores-
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cence signal for hNP-AC compared to hNPC (Fig. 2.1B).
The hNPC and hNP-AC were prepared with a cell concentration of 1 · 105/ml (6 samples per
cell line). Measurement was performed continuously every 3rd day (d) for a measure period of
22d.
Figure 2.1: Correlation between fluorescence and cell number for hNPC and hNP-AC.
A: Conversion of resazurin by metabolically active cells results in the generation of a fluorescent prod-
uct proportional to the number of cells (Promega (2006), Technical bulletin).
B: The standard curves for the metabolic assay of hNPC and hNP-AC show significant linear relation-
ships between emission at 590nm and the number of serially diluted cells in the range from 1 ·105 -
8 ·105 cells/ml. Standard curves of hNPC and hNP-AC differed in their gradients. Fluorescence signal
of hNP-AC was higher than the signal generated by hNPC. Regression lines show goodness of fit with
r2 = 0.9374 for hNPC, and r2 = 0.9748 for hNP-AC. Data represent means ± SEM.
2.4.2 Morphological Assay
In vitro proliferation as self aggregating neurospheres is a characteristical feature of hNPC and
offers excellent conditions for high expansion rates (Svendsen et al., 1997; Carpenter et al.,
1999; Ostenfeld et al., 2002). Therefore, an examination under neurosphere culture conditions
seemed reasonable. However, the metabolic assay was not appropriate for intact hNPC and
hNP-AC spheres due to the lack of penetration of the kit components deep into the structures.
Therefore, an alternative, morphological assay was established to estimate cell proliferation
within intact spheres. The spherical nature of the neurospheres allowed the volume (V ) to
be determined from microscopical measurements of diameter (D, Fig. 2.2A) according to the
following formula:
V =
4
3
Π
(
D
2
)3
(2.1)
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To minimize systematic errors concerning the volume calculation of neurospheres, the follow-
ing selection criteria were applied:
I) Only ball-like spheres were assessed;
II) As the shape of neurospheres changed during the experimental period, spheres were
excluded from the experiment;
III) Spheres located at the margin or adherent to the tissue culture plastic were excluded
from the experiment.
The relationship between volume (V ) of a sphere and cell number was investigated by the
following method: neurospheres were carefully transferred with a pipette into 96 well plates
(MicrotestTM) under microscopic control. After measurement of diameter, neurospheres were
dissociated with Accutase (200µl, see chapter 2.1.2) to a single cell suspension. When cells had
sedimented to the ground of the wells, five non-overlapping fields (0.242mm2, magnification of
100x) were photographed and counted using ImageJ 1.41o software. To estimate the total num-
ber of cells of one neurosphere results were extrapolated to the complete well-surface (32mm2).
A significant linear correlation (r2 = 0.94) between cell number (n) and diameter (D) of a sphere
(Fig. 2.2B) was found, given by the following equation:
n(D) = 1.72 ·105 ·D3; [D in mm] (2.2)
Thus, it was possible to estimate the total cell number within hNPC neurospheres by measuring
the sphere diameter, assuming that the linear correlation between the volume of the spheres and
the number of cells within the spheres was maintained during cultivation. Proliferation was
determined by measuring increasing neurosphere volume (∆V ) over time (t). Isolated neuro-
spheres were cultured in 12-well culture plates (Greiner Bio-One) at 37◦C in a 5% CO2 at-
mosphere. The increase in size of neurospheres was monitored under the microscope (Leica,
DMI 4000B), images captured using a digital camera (JVC, KY - F75U) and measured using
the software Diskus 4.80. Two diameters in orthographic projection were recorded (Fig. 2.2A).
The arrithmetic mean of the two diameters was used for further calculations, assuming a nearly
round sphere. Media was changed every other day. Growth of approximately 80 individual
neurospheres was documented every 24h for a time period of 14d.
Different sizes of neurospheres were monitored to investigate, whether proliferation of spheres
depends on their size. Selected spheres showed diameters in between 70µm (smallest spheres)
to 450µm (largest spheres) at the beginning of the experiment (day 1; d1). Measurement was
terminated when spheres reached a diameter greater than 1000µm.
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Figure 2.2: Correlation between neurosphere volume and cell number.
A: The lightmicroscopic image shows a hNPC-neurosphere that was cultured individually for the mor-
pholocial assay. The diameters were registered in orthographic projection each 24 hours and used for
ongoing calculations. B: The diagram shows the standard curve of the morphological assay with a
positive linear correlation (r2 = 0.94) between cell number and volume of a sphere (n = 18).
2.4.3 Calculations of Proliferation and Doubling Time
Proliferation activity of cells in culture is characterised by a sigmoidal pattern containing four
different phases of growth (Fig. 2.3). Within the first phase, when cells adapt to culture, the
number of cells is nearly constant. Thereafter, the culture proliferates exponentially, illustrated
by a constant slope in the logarithmic scaled diagram (log phase), until saturation is achieved
(plateau phase). Due to a faster cell death compared to cell division, the latest phase is char-
acterised by a declining cell number.
Cell proliferation kinetics during log phase are characteristic for a particular cell line and it is
during this phase when the multiplication rate or the Doubling Time is calculated (McAteer J.A,
2001). The multiplication rate (r) is the number of generations that occur per time unit and is
expressed as population doublings per time. The doubling time (DT ) is reciprocal to r and
expresses the time in hours taken for cell number to double:
DT =
1
r
. (2.3)
As the DT varies strongly in the different growth phases the cell line is currently in (Fig. 2.3),
a time averaged value over all growth phases has no significance. Therefore the analysis was
performed on the logarithmic growth phase. A time interval of δ t = 72 for the metabolic assay
and a time interval of δ t = 24 for the morphological assay was chosen.
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Figure 2.3: Schematic drawing of growth phases for cells in culture.
The graph outlines the classical phases of growth under cell culture conditions of non-transformed cell
lines. Cell proliferation kinetics during the log phase are characteristic for a particular cell type under
defined conditions.
In the metabolic assay DT could be calculated with a cell number over time function. Mean
values of cell amount over the series of experiments could be easily generated. However, for
the morphological assay a calculation of a mean value concerning cell amount would have been
inaccurate, because differently sized spheres showed different cell numbers at the beginning and
throughout the experiment. Thus, a calculation of DT using a cell number over time function
would have only been possible for one single sphere. Since a result including data of only one
series of sphere measurements, would have lacked general significance, a calculation of DT
including data of more spheres was needed. Therefore, a correlation between the expansion of
the cell volume expressed by the difference volume (∆V ) and the mean cell volume (V t1,t2) was
used. The difference volume (increasement) per time (∆V /∆t) was calculated by
∆V
∆t
=
Vt2−Vt1
t2− t1 , (2.4)
where Vt1 represents the volume of a sphere at the point in time t1 and Vt2 the volume of the
same sphere at the point in time t2. The mean volume (V t1,t2) was determined by
V t1,t2 =
Vt2 +Vt1
2
. (2.5)
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In case of an exponential growth, the increasement of the sphere correlates linear with the mean
volume (see Fig. 2.4), whereby the constant correlation coefficient, the slope (α) of the plot, is
reciprocal to the desired doubling time:
DT =
ln2
α
. (2.6)
The derivation of this correlation is given in the appendix (see additonal data, chapter 9.1). The
averaged doubling time was calculated by the slope of the regression line, found by plotting the
data of all neurospheres.
mean Volume V
in
cr
ea
se
m
en
t Δ
V/
Δt
α
Figure 2.4: Correlation between the increasement of the neurospheres and their mean volume in case of
logarithmic growth.
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3.1 Characterisation of hNPC
One goal of this study was to define the cell population in the hNPC-neurospheres. Character-
isation of the hNPC cells was necessary because it provides the baseline phenotype for the in
vitro differentiation of hNP-AC, a prerequisite for later in vivo transplantation studies.
3.1.1 Progenitor/Stem Cell Related Markers in hNPC
In a first stage the expression profile of the stem cell related markers nestin, SOX2, musashi
and CD133 (Prominin-1) was investigated. The hNPC grew as neurospheres which appeared
as large, tightly bound clusters of cells. Plating of the neurospheres on to PLL/laminin coated
dishes induced rapid adherence to the substrate with flattening of the sphere as cells migrated
away in a radial pattern (Fig. 3.1B).
Quantitative immunocytochemistry of the monolayers around the spheres revealed that the ma-
jority of the hNPC were immunopositive (+) for nestin (Fig. 3.1B and C), an intermediate
filament protein expressed in undifferentiated neuroepithelial stem and precursor cells derived
from human first trimester forebrain- and spinal cord tissue (Carpenter et al., 1999; Wright
et al., 2003). Quantification revealed that 91 ± 3.4% of hNPC were nestin-positive (Fig. 3.11).
Cryosections of hNPC-neurospheres showed an even, ubiquitous distribution of nestin staining
within the spheres (Fig. 3.1A).
The migrating, nestin-positive cells displayed heterogeneous morphologies including small
round-, bipolar as well as large polymorphic appearances (Fig. 3.1C). Interestingly, some bipo-
lar cells were able to grow on top of the polymorphic cells (Fig. 3.2D, white arrows).
The proportion of nestin immunoreactive cells was maintained during in vitro expansion (in-
vestigation was performed up to P11). Likewise, there was no significant alteration of nestin
mRNA expression during in vitro expansion (Fig. 3.1D). Complete images of mRNA samples
with kb-ladder, GAPDH internal controls as well as positive- and negative controls for each
investigated marker are attached in the appendix (see additional data, Fig. 9.1).
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Figure 3.1: Expression of the stem cell marker nestin by hNPC.
A: The cryosection of a hNPC-neurosphere (P6) showed an even and ubiquitous staining pattern for
nestin immunoreactivity (red). B: A hNPC-neurosphere (P11) plated on to PLL/laminin for one day
prior to fixation showed rapid attachment and a wave of radial cell migration. The boxed region ex-
emplarily shows one out of four areas per neurosphere, which were counted for statistical evaluation
of immunoreactivity. C: Nestin+ cells (red) with heterogeneous morphologies migrate out of the neu-
rosphere; nuclei were counterstained with DAPI (blue). D: RT-PCR shows that nestin mRNA was
continuously expressed in different hNPC passages over time in culture (P2, P3, P7).
The hNPC were immunoreactive for SOX2 (Fig. 3.2), a nuclear transcription factor of the sex-
determining region Y (SRY)-related high mobility group (HMG) box family, which is most
commonly associated with non-committed stem and precursor cells in the developing nervous
system (Ellis et al., 2004; Fong et al., 2008). There was an even distribution of SOX2+ cells
in hNPC-neurosphere cryosections (Fig. 3.2A), showing co-expression for nestin (Fig. 3.2C).
Quantification demonstrated that 89.2± 2.7% of hNPC were SOX2+ within the wave of migra-
tion cells (Fig. 3.2B and Fig. 3.11). Immunoreactivity for SOX2 was mainly localized in the
cell nuclei with a slight cytoplasmatic component. Co-expression of the two stem cell related
markers (nestin and SOX2) was observed in 82.7 ± 3.4% of hNPC (Fig. 3.2C, D and E). Only
6.9 ± 2.8% of hNPC, whose nuclei were visible with DAPI staining, showed no immunoreac-
tivity for SOX2 or nestin antibody.
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Figure 3.2: Co-expression of the stem cell markers SOX2 and nestin by hNPC.
A, C: The cryosection of a hNPC-neurosphere (P6) shows an even and ubiquitous distribution of
SOX2+ (green) cells with co-expression of nestin (red, C).
B, D: SOX2+ (green) hNPC migrated out of a PLL/laminin plated neurospheres (located outside the
image frame). SOX2 is co-expressed with nestin (red, D). The arrows indicate bipolar cells with long
processes that grow on top of other hNPC.
E: Quantification shows that the majority of cells co-expressed SOX2 and nestin (left column). A
small percentage of hNPC expressed only one of the markers (centre columns) while some cells did
not express either markers (right column). Data are means ± SEM of P3-P11 of hNPC.
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The hNPC were immunoreactive for Musashi-1 (Fig. 3.3A and B), an evolutionary conserved
stem-cell RNA-binding protein, that controls neural cell fate (Okano et al., 2002). There was an
even staining pattern of Musashi-1 immunopositive cells in cryosections of hNPC-neurospheres
(Fig. 3.3A). Musashi-1 immunopositive cells, which had established aggregates of cells at the
limit of the migration wave showed heterogeneous morphologies with bipolar and polymorphic
cells (Fig. 3.3B). About 91.8± 2.0% of hNPC were immunoreactive for Musashi-1 (Fig. 3.11).
This proportion remained constant over time in culture.
The hNPC expressed mRNA of CD133 (Prominin-1, Fig. 3.3C), a surface marker endowing
self-renewal and multi-lineage differentiation capacity in neurosphere-initiating cells (Uchida
et al., 2000; Piao et al., 2006). The expression profile for CD133 mRNA was constant over time
in culture.
A: The cryosection of a hNPC-neurosphere (P6)
shows an uniform staining pattern for Musashi-1
(green) antibody.
B: Single growing Musashi-1+ (green) hNPC (P11)
show heterogeneous morphologies; nuclei were
counterstained with DAPI (blue).
C: RT-PCR shows that CD133 mRNA was uniformly
expressed in hNPC-passages up to P7.
Figure 3.3: hNPC immunoreactivity for Musashi-1 and expression of CD133 mRNA.
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3.1.2 Multipotency of hNPC
Immunostaining for TuJ1 and MAP2ab was used to identify spontaneously differentiating neu-
rons of variable maturity (Dehmelt and Halpain, 2005). Staining for TuJ1 identified individual
cells scattered throughout the hNPC-neurospheres. These cells showed no distributional pref-
erence within the neurospheres, being located at the outermost margins as well as the center
(Fig. 3.4A). Many cells showed a weak immunoreactivity for TuJ1. Only a few cells with an
intensive staining migrated out of the hNPC-neurospheres (white arrow Fig. 3.4B).
Figure 3.4: Scattered expression of neuronal markers TuJ1 and MAP2ab by hNPC.
A: Cryosection of a hNPC-neurosphere (P6) shows a few randomly localized TuJ1+ (red) cells. B: A
wave of migrating cells forming around the plated sphere with many weakly stained, non-committed
TuJ+ cells. The white arrow indicates an intensively stained migrating TuJ1+ (red) cell. C: Cryosection
of a hNPC-neurosphere (P6) shows a thin band of strong MAP2ab immunoreactivity (red) around
the neurosphere. D: Some MAP2ab+ (red) hNPC migrate out of a neurosphere (P3). Nuclei were
counterstained with DAPI (blue). The white arrows mark two bipolar, intensely stained MAP2ab+
cells growing over more weakly stained- or unstained cells.
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Staining of cryosections of hNPC-neurospheres with anti-MAP2ab showed weak immunore-
activity in the center of spheres (Fig. 3.4C). At the outer margin, there was a thin band of
relatively strong MAP2ab immunoreactivity (Fig. 3.4C), which extended annularly around the
neurosphere. Some migrating bipolar hNPC were intensely MAP2ab immunoreactive (white
arrows Fig. 3.4D and Fig. 3.6). MAP2ab+ cells had a bipolar morphology and adhered singu-
larly on PLL/laminin coated surface (Fig. 3.6) or on top of other cells (Fig. 3.4D, white arrows).
Figure 3.5: Expression of the astrocytic marker GFAP by hNPC.
A: A cryosectioned hNPC-neurosphere (P6) shows randomly distributed GFAP+ cells (green). B,C:
Clusters of individual GFAP+ cells (P6, green) migrating on PLL/laminin were big in size and adopted
polygonal morphologies. Many DAPI stained nuclei (blue) labelled cells, negative for GFAP staining.
D: A thin band of GFAP mRNA was expressed in hNPC.
To indicate presence of astrocytic precursor cells, immunofluorescence for GFAP, CD44 (HCAM/
Hermes antigen), vimentin and S100β was performed. Furthermore, the mRNA-expression
profile of these markers was also examined with RT-PCR.
Some hNPC were immunoreactive for GFAP (Fig. 3.5A, B and C), an astrocyte-specific type
III intermediate filament protein widely used in CNS cell characterisation (Eng, 1985). The
GFAP staining pattern in cryosectioned spheres was not ubiquitous; individual GFAP+ cells
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were scattered throughout the sphere (Fig. 3.5A). GFAP+ cells, that had established aggregates
at the limit of the migration wave, were large in size and had a polygonal, flat epithelial cell-like
morphology (Fig. 3.5C). Quantification demonstrated the presence of 23.7 ± 2.3% of GFAP+
cells in younger (P3) and older (P11) culture passages of hNPC (Fig. 3.11). The apparently
constant proportion of cells differentiating to an astrocytic phenotype was supported by RT-
PCR, which demonstrated the presence of a similarly thin band of GFAP mRNA expression at
different passages in hNPC (Fig. 3.5D).
Double immunofluorescence revealed many non-committed hNPC with only weak staining for
GFAP and/or MAP2ab antibody. Occasional cells, which had migrated out from the sphere,
sometimes intensely labelled for either MAP2ab or GFAP, but never for both antigens. These
2 populations of cells were morphologically and antigenically different: the large epitheloid
GFAP+ cells were readily discernable from the smaller bipolar MAP2ab+ cells; other cells
nearby the sphere were negative for both antigens (see arrows Fig. 3.6).
Figure 3.6: MAP2ab+ hNPC and GFAP+ hNPC develop heterogeneous morphologies.
GFAP+ (green) cells with a large, polygonaland morphology (arrow pointing to the left) contrasted to
MAP2ab+ (red) cells, which were smaller and adopted a bipolar morphology (arrow pointing to the
right). Some cells with small densely packed nuclei were negative for both antigens (arrow pointing
upwards).
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The majority of hNPC was immunoreactive for vimentin (Fig. 3.7A, B and C), another type
III intermediate filament protein, expressed in astrocytic progenitor cells (Chu et al., 2001). Vi-
mentin+ cells were ubiquitously distributed within cryosections of spheres with an even staining
pattern (Fig. 3.7A). Quantitative analysis revealed a presence of 96.8 ± 1.1% vimentin+ cells
(Fig. 3.11). Solitary localized vimentin+ cells were polymorphic with large cell bodies (Fig.
3.7C). The size of the mRNA vimentin band, generated by RT-PCR, was constant in differ-
ent hNPC passages (Fig. 3.7D). Vimentin+ cells also co-expressed either Musashi-1, S100β
or GFAP (Fig. 3.8). Figure 3.8 demonstrates the heterogeneous morphologies adopted by the
hNPC population, when exposed to the PLL/laminin substrate.
Figure 3.7: Vimentin expression by hNPC.
A: Vimentin+ (red) cells were evenly distributed within a cryosection of a hNPC-neurosphere (P3).
B: Vimentin+ hNPC grew in a radial manner when plated on to PLL/laminin (P3). C: Individual
vimentin+ hNPC (P11) were large and polymorphic in shape. D: RT-PCR revealed similarly sized
bands of vimentin mRNA from hNPC at different passages in culture (P2, P3, P7).
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A-C: Vimentin+ (red) hNPC (P4, P11) co-expression
with GFAP (A, green), with Musashi-1 (B, green)
and S100β (C, green). The images demonstrate the
variety of cell morphologies, which developed spon-
taneously after seeding on to PLL/laminin substrate.
The hNPC tended to adopt a large, polymorphic
appearance, or smaller, bipolar morpology with long
processes. Nuclei were counterstained with DAPI
(blue).
Figure 3.8: hNPC co-express vimentin with GFAP, Musashi-1 or S100β .
The hNPC were immunoreactive for S100β (Fig. 3.9A, B and D), a Ca2+, Cu2+ and Zn2+ bind-
ing member of the S100-calmodulin-troponin superfamily that participates in remodelling com-
ponents of the astrocytic cytoskeleton such as microtubules, GFAP or vimentin (Bianchi et al.,
1993; Sorci et al., 1998). S100β+ cells were randomly, but not ubiquitously, localized within
cryosections of hNPC-neurospheres (Fig. 3.9A). Quantification revealed that 17.6 ± 2.1% of
hNPC were immunoreactive for S100β (Fig. 3.11). Preferentially the hNPC-population, which
adopted a polymorphic appearance (Fig. 3.9B and D) demonstrated S100β immunoreactivity.
The intensity of the staining within a cell was uneven: the nucleus with higher fluorescence
intensity could be clearly discerned from the cytoplasm (Fig. 3.9B). S100β mRNA of hNPC
was expressed at a constant level in the different passages (Fig. 3.9C).
In early hNPC passages (e.g. P3) of hNPC there were hardly any CD44 (Hermes antigen,
HCAM) immunoreactive cells detectable. The CD44 transmembrane glycoprotein has been
implicated in cell-matrix adhesion and matrix-mediated cell signaling (Naor et al., 1997) and
is expressed by astrocyte-restricted progenitor cells (Liu et al., 2004). It has been identified as
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Figure 3.9: S100β expression by hNPC.
A: Some S100β+ (green) cells were randomly localized within a cryosection of a hNPC-neurosphere
(P6). B, D: S100β+ cells migrated out of a neurosphere (P11) with their nuclei showing higher fluo-
resence intensity compared to their cytoplasmn. Cell nuclei were counterstained with DAPI (blue, D).
C: S100β mRNA was expressed constantly in different hNPC passages.
an early marker of astrocytic differentiation (Vogel et al., 1992; Moretto et al., 1993). In older
hNPC culture passages (e.g. P11) CD44+ cells were rarely detectable (data not shown). A thin
band of CD44 mRNA was expressed in hNPC, that remained constant in different hNPC pas-
sages (Fig. 3.10).
A spontaneous differentiation to cells of the oligodendroglial lineage was not observed. Stain-
ing with the oligodendroglial markers, for example anti-O1, anti-O4 and anti-GalC showed no
immunoreactivity (data not shown).
In summary, the immunocytochemical characterisation and mRNA expression analyses con-
firmed that the purchased hNPC contained cells, which demonstrated typical neural progenitor
characteristics. Approximately 90% of hNPC expressed the stem/progenitor cell markers nestin,
SOX2 and Musashi-1 (Fig. 3.11).
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Figure 3.10: CD44 mRNA expression by hNPC.
RT-PCR shows a thin band of CD44 mRNA in different hNPC culture passages.
Furthermore, hNPC represented a heterogeneous population, varying in morphology and marker
expression. The hNPC expression patterns could be attributed to undifferentiated-, astrocytic or
neuronal progenitor cells, but not to an oligodendroglial cell lineage.
The amount of cells expressing characteristic astrocyte-related markers (i.e. S100β , GFAP) was
less than 25% in hNPC (Fig. 3.11). A table summarizing percentage of phenotypes is attached
in the appendix (see additional data, Table. 9.1).
Figure 3.11: Immunocytochemical expression profile of hNPC for stem/progenitor cell and astrocytic mark-
ers.
The diagram shows the proportion of cells that were immunoreactive for stem/progenitor cell-related
markers (nestin, SOX2, Musashi-1) and astrocyte-related markers (vimentin, S100β , GFAP). Pro-
vided data are means ± SEM of immunoreactivity profile for hNPC (P3-P11), migrating out of
spheres, which had been plated on to PLL/laminin for one day.
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3.2 Proliferative Activity of hNPC
In presence of growth factors EGF and bFGF, the hNPC were kept in a proliferative state and
could be cultured over a period of 6-8 months. The hNPC showed immunoreactivity for the
proliferation marker Ki67, which is expressed in late G1/S/G2/M phases of the cell cycle (Ver-
heijen et al., 1989; Schlu¨ter et al., 1993). Adherent cell monolayers as well as neurosphere-
cryosections showed Ki67+ hNPC (Fig. 3.12B and C). The DAPI+ nuclei showed a normal
appearance within the spheres (Fig. 3.12A) without indications of cell death, such as by the
presence of nuclear fragmentation. Ki67+ hNPC nuclei were evenly distributed in the sphere
without any preference for being located at the outermost margin or at the centre (Fig. 3.12B).
A: Nuclei within hNPC-neurosphere cryosections
stained with DAPI (blue) show normal apperance
without indications of cell death, such as by the
presence of nuclear fragmentation.
B: The same neurospheres-cryosection also labels for
Ki67+ (green) mitotic cell nuclei. The Ki67+ cells
were evenly distributed within the neurosphere.
C: Vimentin+ (red) hNPC (P3), which were plated on
to PLL/laminin substrate, showed immunoreactivity
for Ki67 (green) antibody.
Figure 3.12: Ki67 expression by hNPC.
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3.2.1 Metabolic Assay
To quantify the proliferative activity in hNPC a 2D metabolic assay and a 3D morphological
analysis (see chapter 3.2.2) were performed. Thus, DT and r could be determined.
The metabolic assay measured proliferation of hNPC, which were grown as adherent cell cul-
tures on PLL/laminin substrate. The hNPC (P3) showed a sigmoidal growth curve over the 22
days of measurement (Fig. 3.13A). From day 1-7, growth followed a logarithmic function. In
this phase the characteristic DT of 1.68 ± SEM 0.1 days was determined. Between day 17-20
the cell number reached its maximum with 2.5 ·106 cells/ml (i.e. 6.5 ·105/cm2). Subsequently,
the number of cells decreased and measurement was stopped.
Values for r, which is reciprocal to DT (see chapter 2.4.3) changed over time (Fig. 3.13B). In
the logarithmic growth phase, r was maximal with values of 0.6/24h (Fig. 3.13B, day 4 and
7). When monolayer cultures of hNPC reached confluency, r decreased. Negative values for r
indicate cell loss (Fig. 3.13B, day 19 and 22).
Figure 3.13: Growth curve of hNPC and decline of multiplication rate in the metabolic assay.
A: The hNPC (P3) showed a sigmoidal pattern of growth. In the beginning growth could be described
by a logarithmic function (DT = 1.68± SEM 0.1 days). Between day 17 and 20 there was a maximum
with 2.5 ·106 cells/ml. B: Multiplication rate (r) of hNPC (P3) decreased over time in the metabolic
experiment. Values for r were highest in the logarithmic growth phase at day 1-7. At day 19 and 22 r
was negative due to cell decline. Data are means ± SEM of six independent cultures.
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3.2.2 Morphological Assay
The 3D morphological assay performed in this study allowed an estimation of cell proliferation
in intact neurospheres. An example of the increase of neurosphere volume over time (as well as
the estimated cell number) is demonstrated for one individual hNPC-neurosphere (P3) in Fig-
ure 3.14A. The growth curve describes an exponential function, with the neurosphere volume
quadruplicating over the 14 day measuring period. All hNPC-neurospheres selected for this
experiment followed an exponential function of growth. The hNPC-neurospheres observed in
this experiment were selected from both, young (P3) and older (P11) passages.
The volume [mm3] over time [d] diagram (Fig. 3.14A) did not allow a general conclusion and
calculation of a mean DT , because the plotting of data from all hNPC-neurospheres was not
possible with this function (see chapter 2.4.3). Therefore a data plot of the difference in volume
(∆V ) as a function of mean sphere volume (V t1,t2) was selected (Fig. 3.14B). A pair of values
represents the volume difference of a sphere (∆V ) over the period of time (t2 - t1; i.e. 24 hours)
in relation to the mean volume of the sphere at time point t1and t2.
Figure 3.14B reflects data from all hNP-neurospheres selected for this experiment. The scat-
terplot describes a linear function (r2 = 0.84) with a constant logarithmic increase of sphere
volume, i.e. increase in cell number of the spheres. As described earlier (see chapter 2.4.3,
formula 9.1) the slope (α) of the regression line represents the exponent of growth with α =
0.1923 ± 0.007347. Thus, DT resulted from the given formula:
DT =
ln2
α
= 3.46 (3.1)
The growth curve in the 3D morphological assay described constant logarithmic growth, so that
the DT of 3.46 days (i.e. r of 0.28), did not decline over duration of the experiment, in contrast
to the calculated DT and r in the 2D metabolic assay.
Distribution of values is not even in diagram 3.14B, because more values were available for
small- and middle-sized spheres, varying from 0.03 to 0.13mm3 in volume. Large spheres,
achieving a volume greater than 0.2mm3, often had to be excluded from the experiment due to
their shape change from spherical to ovoid.
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A: The graph shows one hNPC-neurosphere increas-
ing in volume over a time period of 14 days. The
function describes exponential growth. The increase
of volume was monitored every 24 hours, serving as
an indirect measure for the increase in cell number.
B: This dataplot depicts the correlation between the
absolute change of the sphere volume and the mean
sphere volume for all hNPC-neurospheres (n = 133).
The regression line describes a constant logarithmic
growth throughout the duration of the experiment (r2
= 0.84), whereby the slope (α = 0.19) corresponds to
a mean doubling time (DT ) of 3.46 days.
Figure 3.14: Constant logarithmic growth of all hNPC-neurospheres.
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The volume of spheres and time point of measurement did not influence DT critically: the data
of the hNPC-neurospheres examined for 14 days in this experiment did not provide a significant
correlation for change of DT with increase of sphere volume (Fig. 3.15A). Smaller spheres
showed no characteristic difference in DT compared to larger spheres. There was no significant
correlation between DT and point in time during the measurement (Fig. 3.15B). Both graphs in
Figure 3.15 show continuous variation of DT .
The DT did not decrease over time, in contrast to the calculated DT in the metabolic assay.
Figure 3.15: Doubling Time (DT ) does not correlate with sphere volume (A), or with point in time during the
measure period (B).
A: Variation of DT for single spheres with different volumes.
B: Variation of DT for single spheres when measure time [d] proceeded.
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3.3 Characterisation of hNP-AC
To generate unipotent aggregates from hNPC capable of giving rise to pure populations of
hNPC-derived type I astrocytes (hNP-AC), that are subscribed to comprise CNS regenerative
capacity, neurospheres were incubated with the media supplements LIF and BMP4 (Weible and
Chan-Ling, 2007) for at least 8 passages.
The next section outlines the contrast in between the hNPC prior to- and after differentia-
tion to hNP-AC. Characterisation of the differentiated cells was performed using the same
immunocytochemical- and RT-PCR mRNA-expression analyses as were used for hNPC. The
results for hNP-AC will be compared to those obtained for hNPC (see chapter 3.1).
It will be shown, that the expression of stem/progenitor cell-related markers did not signifi-
cantly change following differentiation to hNP-AC, whereas the proportion of cells expressing
astrocyte-related markers increased significantly.
3.3.1 Stem/Progenitor Cell Related Markers in hNP-AC
The hNP-AC were investigated for expression of the stem/progenitor cell-related markers nestin,
SOX2, Musashi-1 and CD133, which had already shown to be expressed in a high number in
hNPC prior to differentiation (see chapter 3.1.1).
Immunocytochemistry showed that the stem cell markers nestin, SOX2 and Musashi-1 were
evenly and ubiquitously distributed within cryosections of the spheres without any preference
to being located at the centre- or at the outermost margins of the spheres (Fig. 3.18A, C and
Fig. 3.17A). The vast majority of cells migrating out of spheres that had been seeded on to
PLL/laminin substrate showed immunoreactivity for nestin (Fig. 3.18B), SOX2 (Fig. 3.18D)
and Musashi-1 (Fig. 3.17B). Quantification demonstrated that 89.2 ± 3.8% of hNP-AC were
immunoreactive for nestin, not significantly differing from the percentage of nestin+ cells in
hNPC. Similarly, the level of nestin mRNA (Fig. 3.16) was maintained during in vitro differen-
tiation from hNPC to hNP-AC and remained unchanged at the different culture passages (Fig.
3.16). The CD133 mRNA expression also showed no change in hNP-AC when compared to
hNPC (Fig. 3.16).
SOX2 expression was detected in 88.0 ± 3.6% of hNP-AC migrating on the PLL/laminin sub-
strate; not significantly different from the proportion of SOX2 expressing cells in hNPC cul-
tures (Fig. 3.25). Similiar to hNPC, the distribution of SOX2 immunoreactivity in hNP-AC was
mainly localized to the nuclei (Fig. 3.18D and F). Cells in cryosections of spheres (Fig. 3.18E)
as well as migrating cells (Fig. 3.18F) demonstrated co-localization for the stem/progenitor cell
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Figure 3.16: Nestin and CD133 mRNA expression profiles during the BMP4/LIF-mediated differentiation of
hNPC to hNP-AC.
RT-PCR of the expression of nestin and CD133 mRNA for hNPC (four bands on the left) and the
differentiated hNP-AC (four bands on the right). There was no significant change in mRNA expression
of either mRNA following BMP4/LIF treatment. Samples were selected from different passages of
hNPC (P2, P3, P7) and from different passages of hNP-AC (P4P5, P4P10, P8P4, P8P12).
markers nestin and SOX2 in hNP-AC.
Immunoreactivity for Musashi-1 was present in 89.2± 3.8% of hNP-AC migrating out of plated
spheres (Fig. 3.17B and Fig. 3.25). Although the quantity of Musashi-1 immunoreactive
cells did not significantly change, there was a qualitative change in the staining compared to
Musashi-1 immunoreactive hNPC: in hNPC, staining with Musashi-1 antibody showed an even
distribution, smoothly filling out the cell (see chapter 3.1.1, Fig. 3.3B), whereas the Musashi-1
staining in hNP-AC appeared more patchy (Fig. 3.17B).
Figure 3.17: Musashi-1 expression by hNP-AC.
A cryosection of an hNP-AC sphere (A) and single cells migrating over PLL/laminin substrate (B)
demonstrate immunoreactivity for Musashi-1 (green). Musashi-1+ hNP-AC display a patchy staining
pattern (B) throughout the cell cytoplasm.
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Figure 3.18: Co-expression of the stem cell markers nestin and SOX2 by hNP-AC.
A cryosection of a hNP-AC sphere (A,C,E) and cells migrating out of spheres plated on to
PLL/laminin (B,D,F) show immunoreactivity for nestin (red) and SOX2 (green). Both stem cell
markers colocalize in hNP-AC cryosections (E) and in migrating cells (F).
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3.3.2 Differentiation Results in a Highly Enriched Population of hNP-AC
Most hNP-AC were immunoreactive for vimentin (92.9 ± 3.8%) and GFAP (92.5 ± 3.4%; Fig.
3.20A-F). The values for vimentin+ cells were similar between hNP-AC and hNPC, however
the number of GFAP+ hNP-AC was significantly greater than that of hNPC (Fig. 3.25). These
observations were supported by RT-PCR: whereas only a thin band of GFAP mRNA was de-
tectable in the hNPC (Fig. 3.19A), a broad band of GFAP mRNA was observed in the hNP-AC.
Semi quantitative analysis of GFAP mRNA expression in ratio to the expression of the house
keeping gene GAPDH (Fig. 3.19B) resulted in a change, that was significant (p < 0.05).
The vimentin+/GFAP+ cells were ubiquitously distributed within cryosections of hNP-AC spheres
and when plated on to PLL/laminin substrate adopted a large, polygonal, flattened morphology
sometimes with process indicating their orientation of migration away from the position of the
plated sphere. Vimentin and GFAP co-localized within the cytoplasm of these cells (Fig. 3.20E
and F).
Figure 3.19: Significant increase in GFAP-mRNA expression by hNP-AC.
Expression of vimentin and GFAP mRNA is shown for hNPC (A, four bands on the left) and the dif-
ferentiated hNP-AC (A, four bands on the right) in comparison. Samples were selected from different
passages of hNPC and hNP-AC (as indicated). A: Differentiation to hNP-AC resulted in an increase
of GFAP mRNA expression. Vimentin mRNA expression did not change after differentiation.
B: Statistical analysis of the marker genes showed a significant increase of GFAP mRNA expression
in hNP-AC (∗: p < 0.05).
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Figure 3.20: Expression of the astrocyte-related markers vimentin and GFAP in hNP-AC.
A-F: hNP-AC show immunoreactivity for vimentin (red) and GFAP (green). A,C: Vimentin+ (A) and
GFAP+ (C) cells are ubiquitously distributed within a cryosection of a hNP-AC-sphere.
B,D: Vimentin+ (B) and GFAP+ (D) cells, migrating on PLL/laminin substrate. E,F: Colocalization
of vimentin and GFAP within a cryosectioned sphere (E) and in individual cells migrating on the
PLL/laminin substrate (F). Cell nuclei were counterstained with DAPI (blue, F).
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The differentiated hNP-AC also showed immunoreactivity for S100β (Fig. 3.21) colocalizing
with vimentin (Fig. 3.21D). The vimentin+/ S100β+ hNP-AC adopted, as described earlier, a
polygonal morphology with processes indicating the route of migration away from the plated
sphere. Quantification of RT-PCR indicated that S100β mRNA expression remained constant
over time in culture, even after differentiation to hNP-AC (Fig. 3.23). However, the cellular dis-
tribution of S100ß protein, identified by immunocytochemistry, showed a significant increase
from 17.6 ± 2.1% to 79.4 ± 1.7% (Fig. 3.25). In addition, cryosections of hNP-AC demon-
strated a homogeneous distribution of S100β immunoreactivity (Fig. 3.21A) in contrast to the
heterogeneous distribution in hNPC spheres (see chapter 3.1.2, Fig. 3.9A). Furthermore, stain-
ing of adherent S100β+ hNPC revealed that the nucleus had an intense fluorescence that allowed
its clear visual discrimination from the lower immunoreactivity of the cytoplasm (see chapter
3.1.2, Fig. 3.9D). In contrast, the S100β+ hNP-AC appeared uniformly immunoreactive, with
their nuclei hardly distinguishable from the cytoplasm (Fig. 3.21B and C).
Figure 3.21: Expression of the astrocyte related markers vimentin and S100β by hNP-AC.
A: The cryosection of a S100β+ (green) hNP-AC-sphere shows an even and area wide staining pat-
tern. B, C: S100β+ hNP-AC migrate out of PLL/laminin plated spheres. The hNP-AC show an
uniform staining pattern, such that nuclei could hardly be distinguished from the cytoplasm. D: The
S100β+ hNP-AC co-express vimentin (red). Nuclei were counterstained with DAPI (blue).
56
3.3 Characterisation of hNP-AC
The hNP-AC expressed the CD44 surface antigen on the cell bodies and processes, that ad-
hered to the PLL/laminin substrate showing a distribution consistent with the reported locali-
sation within the plasma membrane (Fig. 3.22B and C; Naor et al., 1997). Almost all CD44+
cells co-expressed GFAP (Fig. 3.22D). The CD44+ cells were ubiquitously localized within
cryosections of hNP-AC-spheres with an apparent increase of staining intensity towards the
outer margins (Fig. 3.22A). This observation contrasted to immunocytochemical analysis of
hNPC, where CD44+ cells were hardly detectable.
The increase of CD44 expression detected by immunocytochemistry Fig. 3.22), was supported
by the semi-quantitative RT-PCR analysis that showed a statistically significant increase of
CD44 mRNA (p < 0.05; Fig. 3.23).
Figure 3.22: Co-expression of GFAP and the surface marker CD44 by hNP-AC.
A: CD44+ (red) cells are evenly distributed within a cryosection of a hNP-AC-sphere. B: CD44+
(red) cells migrate out of spheres, which had been plated on to PLL/laminin for one day. Cells
show a distribution consistent with the reported localisation within the plasma membrane. C: Higher
magnification of CD44+ (red) hNP-AC visualizes their stellate cell processes, which expanded at their
tips as they spread over the laminin-coated substrate. D: All CD44+ (red) hNP-AC co-express GFAP
(green). Nuclei were counterstained with DAPI (blue).
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Figure 3.23: Increase in CD44-mRNA expression following differentiation to hNP-AC.
A: Expression of S100β - and CD44 mRNA is shown for hNPC (A, four bands on the left) and the
differentiated hNP-AC (A, four bands on the right). Samples were selected from different hNPC
and hNP-AC culture passages (as indicated). There was an increase of CD44 mRNA expression
in hNP-AC compared to hNPC, whereas the S100β -mRNA expression profile did not change. B:
Statistical analysis of marker genes shows a significant increase in CD44 mRNA expression in hNP-
AC compared to hNPC (p < 0.05).
In order to characterise the small population of cells that were negative for markers of the as-
trocytic lineage, immunocytochemistry for oligodendroglial and neuronal cell lineage markers
was performed.
No cells were immunoreactive for the oligodendroglial antigens O1, O4 or GalC. TuJ1 and
MAP2ab immunocytochemistry was used to identify residual cells of the neuronal lineage. Im-
munocytochemistry of cryosections failed to demonstrate any TuJ1+ or MAP2ab+ neurons.
However, occasional migrating TuJ1+ (Fig. 3.24A and B) and MAP2ab+ bipolar cells could be
found amongst the differentiated hNP-AC.
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Figure 3.24: Following differentiation to hNP-AC, only a few cells express markers for neuronal lineage.
The majority of hNP-AC (P4P12), migrating out of PLL/laminin plated spheres, show immunoreac-
tivity for GFAP antibody (green, A-D). Morphology of GFAP+ cells often resembles astrocytic cells.
Only a few residual small sized, bipolar cells show immunoreactivity for TuJ1 (red, A,B) or MAP2ab
(red C,D). Nuclei were counterstained with DAPI (blue).
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In summary - following differentiation - hNP-AC continued to express stem/progenitor cell-
related antigens such as nestin, SOX2 and Musashi-1 (Fig. 3.25, see columns on the left).
Furthermore hNP-AC showed a clear and statistically significant increase of astrocyte-related
antigens such as vimentin, GFAP, S100β (Fig. 3.25, columns on the right) and CD44 co-
expression in all GFAP+ cells.
Only a few residual TuJ+ or MAP2ab+ neurons could be detected within the hNP-AC popu-
lation. A table summarizing the immunohistochemical phenotypes is attached in the appendix
(see additional data, Fig. 9.1).
Concluding, the investigation shows that the hNPC had successfully elaborated towards a highly
enriched population of cells constituting astrocytic lineage characteristics, termed hNP-AC.
Figure 3.25: Overview of immunoreactivity profile of hNP-AC compared to hNPC.
The diagram compares percentages of hNPC (light grey) and hNP-AC (dark grey) plated on to
PLL/laminin for one day that were immunoreactive for the stem/progenitor cell-related markers
nestin, SOX2 and Musashi-1 as well as the astrocyte-related markers vimentin, S100β and GFAP.
Data are means ± SEM. Expression profile data of hNPC are identical to those in Figure 3.11 in
chapter 3.1.2.
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3.4 Proliferative Activity of hNP-AC
Proliferation of hNP-AC was investigated to find out whether the expansion rate differed be-
tween hNPC and differentiated hNP-AC. To determine the DT of hNP-AC the 2D metabolic
assay and 3D morphological analysis were performed as described above for hNPC (see chap-
ter 3.2). In the following it will be shown that both assays resulted in a significantly decreased
DT in hNP-AC, when compared to DT of hNPC.
There were Ki67+ cell nuclei present in long term cultures (P4P13) of hNP-AC (Fig. 3.26B
and C). The Ki67+ nuclei could also be detected in cryosections of hNP-AC-spheres, where
they were distributed evenly throughout the spheres. DAPI staining visualized normal shaped
nuclei within the central part of the spheres without indications of cell death (i.e the presence
of nuclear fragmentation). (Fig. 3.26A and B). The black holes in the sphere, where no DAPI+
nuclei can be detected (Fig. 3.26A), probably result from cryo-preservation artefacts.
A, B: Immunocytochemical staining for DAPI (blue,
A) and Ki67 (green, B) shows an even distribution
within a cryosection of a hNP-AC-sphere (P4P14).
Ki67+ cells are localized in the centre as well as the
margin of the sphere.
C: Several vimentin+ (red) hNP-AC (P4P13), plated
on to PLL/laminin substrate, co-express Ki67 (green).
Figure 3.26: Ki-67 expression by hNP-AC.
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3.4.1 Metabolic Assay
The metabolic assay measured proliferation of hNP-AC, which were grown as adherent cell
cultures for 22 days. The graph in Figure 3.27A includes mean values of 6 independent cultures.
From day 1-4, growth of hNP-AC described a logarithmic function with its characteristic DT .
From day 5-16 the increase of cell number was constant, reaching a maximum of 1 ·106 cells/ml
(i.e. 2.6 ·105cells/cm2). Later the amount of cells declined and measurement was determined.
The diagram 3.27B shows 6 mean values for r of adherent hNP-AC (P4P8) with increasing
time. Values for r decreased when hNP-AC-monolayers reached confluency. Negative values
for r at day 19-22 describe reduction of cells. This growth pattern was similiar to that for hNPC
(see chapter 3.2.1).
Statistical analysis with the Student’s t-test showed a significant difference (p< 0.001) in mean
DT of hNP-AC during the logarithmic growth phase (3.2 ± SEM 0.06d) in comparison to that
for hNPC (1.68 ± SEM 0.03d).
Figure 3.27: Proliferation of hNP-AC in the metabolic assay.
A: Proliferative activity of the hNP-AC (P4P8) was observed for 22 days using the metabolic assay.
Day 1-4 describe a logarithmic growth (DT = 3.2± SEM 0.06d). When hNP-AC monolayers became
confluent, proliferation slowed down and after some time, a reduction of cell number was detectable.
B: The values for r of hNP-AC (P4P8) decrease over time in the metabolic experiment with maximum
r in the logarithmic growth phase at day 1-4. At day 19-22 r is negative due to reduced cell numbers.
Data represent means ± SEM of six independent cultures.
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3.4.2 Morphological Assay
To determine proliferation of hNP-AC under sphere culture conditions, an additional estimation
of the growth rate with the morphologic assay was performed. As described before the calcu-
lation of DT required a volume difference (∆V ) over mean cell volume (V t1,t2) data-plot (Fig.
3.28).
Figure 3.28: Data-plot to calculate DT of all hNP-AC-spheres using the morphological assay.
The graph shows data plotted from all hNP-AC-spheres (n = 57). The linear function describes con-
stant logarithmic growth within the duration of the experiment (r2= 0.52). The slope (α = 0.1355) of
the regression line corresponds to a DT of 5,1d.
The investigated hNP-AC spheres showed a similar growth pattern. The scatter-plot describes a
linear function (r2 = 0.52) with constant logarithmic increase in volume of spheres, i.e. increase
in cell number of spheres. As described earlier (see chapter 2.4.3, equation 9.1) the slope (α)
of the regression line represents the exponent of growth with α = 0.1355 ± 0.01750.
A DT with
=
ln2
α
= 5.1 (3.2)
days resulted, i.e. r of 0.19 days. The growth curve in the morphological assay described a
constant logarithmic growth, so that there was no change of DT (i.e. r) with increasing time in
contrast to r in the metabolic assay.
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In support of the metabolic assay, the morphological-based calculation of hNP-AC DT (5.1 ±
0.19d) was significantly slower than that of the hNPC (3.46 ± 0.28d; p < 0.001).
There was no apparent correlation between DT and the increase of sphere volume (Fig. 3.29A),
nor with the advancement of time (Fig. 3.29B). A continuous variation of DT within the mea-
suring period was observed, giving no indication of a linear correlation. Small spheres demon-
strated similar DT to larger spheres.
Figure 3.29: DT does not correlate with sphere volume, or with point in time in the measuring period.
The DT showed no significant correlation with volume of the spheres or with progress in time within
the 14 day experiment. There was a continous variation in DT . A: Variation of DT for single spheres
at different volumes, B: DT of single spheres at different measuring days within the experiment.
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In the present study the following questions were addressed:
I) To what extent has the in vitro differentiation process altered the cellular characteristic
in hNP-AC?
II) Does the differentiation of hNPC to hNP-AC alter their proliferative activity?
First, the present results confirm that the hNPC demonstrate neural progenitor cell character-
istics. Results were obtained using RT-PCR and double immunofluorescence for particular
markers. The differentiation of hNPC to hNP-AC provoked a significant increase in the pro-
portion of cells labelled with astroglial markers, indicating the generation of a highly enriched
population of astrocytes.
Second, differentiation was also accompanied by a decrease in proliferative activity, as indicated
by the 2D metabolic assay and the 3D morphological analysis.
4.1 Characterisation of hNPC and hNP-AC
Populations of hNPC were characterised prior to- and after in vitro differentiation to hNP-AC
by investigating the proportion of cells expressing stem/progenitor cell-, astrocyte-, neuronal-
and oligodendroglial lineage-related markers.
4.1.1 Methods for Identification of Cellular Content
Double immunofluorescence immunocytochemistry and RT-PCR were applied to observe protein-
and mRNA-expression profiles in both hNPC and differentiated hNP-AC.
Immunocytochemistry is a well established method for cell characterisation. Especially the cell
morphology and marker distribution can be easily observed with this method. Neurospheres
were plated on to PLL/laminin-coated substrates and processed for double immunofluores-
cence. The range of cellular phenotypes were quantified in the migrating cell monolayers,
which formed around the neurospheres, according to quantification methods described earlier
(Svendsen et al., 1998; Ostenfeld and Svendsen, 2004; Piao et al., 2006). In this study, a growth
and spreading period of only 24 hours was selected, because the greater cell density resulting
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from longer growth periods, generated difficulties for accurate cell counting (Carpenter et al.,
1999).
It has been reported that neuronal markers are down-regulated following trituration to a single
cell suspension before seeding, in contrast to seeding intact spheres (Svendsen et al., 1998).
Therefore, the present analysis was performed by maintaining constant seeding conditions for
intact spheres. Furthermore, the central parts of neurospheres were analysed using sphere
cryosections similar to analyses described earlier (Svendsen et al., 1998; Kim et al., 2006; Piao
et al., 2006; Weible and Chan-Ling, 2007).
Even though analysis with immunocytochemistry represents an ideal method to identify the cel-
lular content, only the protein expression level can be determined. Therefore additional analyses
for the stem/progenitor cell-related markers CD133 and nestin were performed using RT-PCR
for mRNA expression profiles. In an attempt to better define the mechanism of differentiation
from hNPC to hNP-AC, the investigation of the astrocytic markers GFAP, vimentin, CD44 and
S100β was also extended to the mRNA level.
However, it should be considered that an interpretation problem remains concerning data from
mRNA expression analysis in contrast to those from immunocytochemistry. It is not clear,
whether a low mRNA expression level represents a general low expression of the investigated
mRNA across the whole population, or whether a few cells expressing high levels of mRNA
may be scattered throughout a generally non-expressing population. Thus, it remains essential
to regard the results of each method in relation to each other.
4.1.2 Stem/Progenitor Cell-Related Markers in hNPC
The first important stage of this investigation was to confirm the neural progenitor cell character-
istics of the hNPC. Markers previously reported to label neural stem/progenitor cells were used
to show the presence of neural progenitors. Immunocytochemistry of the monolayers that had
emerged from plated hNPC-spheres showed 91.0 ± 3.4% nestin-, 91.8 ± 2.0% Musashi-1- and
89.2 ± 2.7% SOX2- immunoreactive cells. These proportions indicate that the hNPC-spheres
were largely composed of non-committed progenitor cells.
Nestin is expressed in the majority of human first trimester-derived forebrain- and spinal cord
neurospheres (Carpenter et al., 1999; Wright et al., 2003; Piao et al., 2006). The high proportion
of nestin protein expression relates to the strong bands of nestin mRNA observed in different
hNPC passages. In addition, the cryosections of hNPC-spheres confirmed nestin expression
throughout the spheres. This supports findings by others in which the majority (> 95%) of hu-
man neural progenitors within neurospheres were reported to be positive for nestin (Svendsen
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et al., 1998).
Co-expression of the markers nestin and SOX2 was present in 82.7 ± 3.4% of hNPC. SOX2
expression has been most commonly associated with non-committed stem and precursor cells
in the developing nervous system (Fong et al., 2008). The 6.9 ± 2.8% of hNPC which were
not immunoreactive for either nestin or SOX2 may include spontaneously differentiated- cells
or apoptotic cells, whose nuclei were not yet degraded and may still be visible with DAPI stain-
ing.
The evolutionarily conserved, neural RNA-binding protein Musashi-1 functions in maintenance
of stem cell fate and differentiation by repressing particular mRNA translation (Good et al.,
1998; Okano et al., 2002). The hNPC in the present study showed 91.8 ± 2.0% immunore-
activity for Musashi-1, providing further evidence of a high proportion of undifferentiated and
proliferative hNPC.
The hNPC also expressed CD133 mRNA, that has been attributed to in vitro neurosphere
initiating- as well as to self-renewal capacity and was initially regarded as a ”new stem cell
marker” (Uchida et al., 2000; Piao et al., 2006).
It has been reported that passage number influences certain properties of in vitro propagated
neurospheres (Svendsen et al., 1998), Piao et al. (2006). Therefore, the expression of a num-
ber of markers was investigated in young and old cell populations with low and higher passage
numbers. However, in the present study the mRNA expression profiles and the immunocyto-
chemical phenotypes of hNPC remained constant in various passages tested.
4.1.3 The hNPC Represent a Heterogeneous Cell Population
The expression of the stem/progenitor cell-related markers was observed in the majority of
hNPC, despite their heterogeneous cell morphologies that developed after plating on to PLL/la-
minin for 24h. The range of morphological phenotypes of cells migrating out of the spheres
included large flat cells, smaller bipolar and multipolar cells similar to observations of others
(Piper et al., 2001; Piao et al., 2006; Weible and Chan-Ling, 2007).
Subpopulations of hNPC expressed the neuronal markers TuJ1 and MAP2ab and others ex-
pressed the glial markers GFAP, vimentin, S100β and CD44. The expression of glial and
neuronal markers has also been reported in sub-populations of isolated human foetal neural
cells that were not cultured as neurospheres (Piper et al., 2000; Svendsen et al., 1997) confirm-
ing thereby that the heterogeneity of hNPC neurospheres was not caused by preparation arte-
facts, but rather to the heterogeneity of the source tissue (Piao et al., 2006). The expression of
stem/progenitor cell-related markers and neuronal or glial markers in the present investigation
indicates a mixture of stem/progenitor- as well as immature neuronal- and glial cell popula-
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tions in hNPC cultures. In addition, Weible and colleagues described that contact with laminin
on coverslips induced the migration of foetal spinal cord hNPC with many of them adopting
a flat, polygonal, epithelial cell-like morphology, resembling type I astrocytes grown in vitro
(Svendsen et al., 1998; Weible and Chan-Ling, 2007). In support of this, the present work
demonstrated the rapid attachment of whole neurospheres to PLL/laminin coated substrate with
migrating cells adopting glial cell-like morphologies (see chapter 3.1.2, Fig. 3.8).
The neuronal markers, TuJ1 and MAP2ab, also labelled some cells in the hNPC, especially
those with small, intensely DAPI-stained nuchlei, which have been suggested to represent im-
mature neuronal cells (Weible and Chan-Ling, 2007). TuJ1 and MAP2ab-positive cells were
also identified in the hNPC-cryosections. MAP2ab antibody has been found to label the den-
dritic processes and cell bodies of more mature neurons arising from spheres (Riederer and
Matus, 1985).
The annular distribution of MAP2ab+ cells was surprising (see chapter 3.1.2, Fig. 3.4C). One
might speculate that the cells located at the outermost margin of the neurosphere were exposed
to different environmental conditions than those in the centre, thus providing a stronger drive
to differentiation into MAP2ab+ neurons. This suggestion agrees with a hypothetical model
about neurosphere size and maturation level in neural progenitor/stem cells (Suslov et al., 2002).
Some MAP2ab+ cells were able to grow on top of other cells (see chapter 3.1.2, Fig. 3.4D).
Interestingly, the other cells were often found to be GFAP-immunoreactive. Such behaviour of
MAP2ab+ cells has also been observed by others (Svendsen et al., 1998). Thus, hNPC-derived
immature astrocytes seemed to provide an attractive substrate for the migrating immature neu-
rons in this study.
The identification and quantification of the sub-population expressing glial markers was a mat-
ter of particular interest in this study. Detailed cell counting of immunoreactive cells showed
that hNPC were composed of populations of cells that were vimentin+ (96.8 ± 1.1%), GFAP+
(23.7 ± 2.3%) and S100β+ (17.6 ± 2.1%). These proportions remained relatively constant at
different passage numbers. In support of this, the mRNA expression profile of vimentin, GFAP
and S100β remained also constant.
The distribution of GFAP+, S100β+ and vimentin+ hNPC cryosections appeared random. This
is in contrast to other reports, which described a tendency for cells in the central region in sphere
cryosections to express a predominantly astroglial phenotype (GFAP+, S100β+ and vimentin+)
and for only few of the cells at the periphery to express these markers (Kim et al., 2006; Weible
and Chan-Ling, 2007). It is possible that the source tissue (i.e human foetal brain) of the inves-
tigated hNPC caused the different marker distribution in the neurosphere to that described by
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others.
The Ca2+ binding protein S100β modulates the assembly and disassembly of microtubules and
intermediate filaments, such as GFAP and vimentin (Bianchi et al., 1993). It has been shown in
vitro by double immunofluorescence that during cytoskeletal rearrangement, the S100β protein
remains associated with the rearranged GFAP and vimentin intermediate filaments (Sorci et al.,
1998). This group observed a preferential association of S100β with GFAP and vimentin near
the nucleus. The immunocytochemical staining pattern in this study showed a similar distri-
bution of S100β in hNPC with a greater intensity of signal near the nucleus, which could be
clearly distinguished from the rest of the cytoplasm (see chapter 3.1.2, Fig. 3.9B). This S100β
staining pattern changed following differentiation to hNP-AC (see beneath, chapter 4.1.4).
The RT-PCR demonstrated thin bands of CD44 mRNA that could be detected in hNPC extracts
at different culture passages. CD44, which has been reported to identify early astrocytic differ-
entiation (Vogel et al., 1992; Moretto et al., 1993; Liu et al., 2004) was hardly detectable with
immunocytochemistry in younger passages, indicating that the proportion of this transmem-
brane protein, was extremely rare, but however present in the mRNA cellular level.
In this study, the potential for spontaneous differentiation could be confirmed for cells of the
neuronal and astrocytic lineage, but not for oligodendroglial cells. Although, the migrating
hNPC around the spheres were immunoreactive for astrocytic and neuronal markers, no im-
munoreactivity for the oligodendroglial markers O1, O4 and GalC could be detected. All of
these antigens are found in oligodendrocytes during maturation (Sommer and Schachner, 1981;
Bansal et al., 1989). The limited incidence of foetal human neural precursors spontaneously
differentiating to an oligodendroglial lineage has also been reported by other authors (Svendsen
et al., 1998; Carpenter et al., 1999; Quinn et al., 1999; Armstrong et al., 2000; Uchida et al.,
2000; Wachs et al., 2003; Piao et al., 2006).
Several strategies have already been performed to increase oligodendroglial development in cul-
tures of foetal human neural cells. Piao and colleagues report that the rarity of O4+ cells (< 1%)
could be slightly increased (< 2%), when plateled-derived growth factor (PDGF) was added to
the medium (Piao et al., 2006). Others reported a dose-dependent increase of O4+ cells follow-
ing triiodothyronine (T3) hormone treatment (Murray and Dubois-Dalcq, 1997; Fritsche et al.,
2005). An increase of oligodendroglial marker expression by neural stem/progenitor cells has
also been observed after withdrawal of growth factors and in the presence of 1% FCS (Wachs
et al., 2003).
There are various attempts to explain the scarcity of in vitro oligodendroglial differentiation
including the suggestion that stem cells do not readily differentiate towards that lineage, or
markers of human oligodendrocytes are inadequate both in vivo and in vitro (Uchida et al.,
69
4 Discussion
2000). Another hypothesis describes that oligodendrocyte precursors may be capable of cell
division for only a certain period of time and then be lost from the cultures during the extended
periods of growth (Svendsen et al., 1998). All these reports are consistent with the present
findings. Some oligodendrocytes (6.0 ± 4%) developed in differentiation studies of our group
from young hNPC cultures after withdrawal of growth factors EGF, bFGF and replacement with
PDGF-AA (20 ng/ml) and T3 hormone-containing B27 (1:50 vol:vol; Fu¨hrmann et al., 2010a).
In conclusion, several possible explanations for the cellular heterogeneity of neurospheres have
been described in literature. One explanation is that the cellular composition of human neuro-
sphere cultures differs as a result of regional heterogeneity of source tissue (Piao et al., 2006).
Another explanation is that different types of clone-forming stem- or progenitor cells might be
present in the neurospheres with distinct developmental potential such as different response to
the growth factors present in the culture medium (Suslov et al., 2002).
In aggreement with these explanations, the hNPC used in the present study contained heteroge-
neous cell populations, consisting of non-commited precursors as well as committed glial and
neuronal cell populations at varying stages of maturation.
4.1.4 Differentiation Leads to a Highly Enriched Population of hNP-AC
The astrocytic sub-population in hNPC seemed to be an attractive surface for neurites to grow
on (see chapter 3.1.2, Fig. 3.4D). Since differentiation of rat embryonic neural precursors to as-
trocytes prior to implantation in spinal cord microlesions has been shown to promote recovery
by supporting axonal regeneration (Davies et al., 2006), we decided to epigenetically modify
the hNPC with the media supplements BMP4 and LIF, according to already established proto-
cols (Weible and Chan-Ling, 2007). It has been shown, that the combination of BMP4 and LIF
reduces the proportion of oligodendroglial and neuronal cells, while increasing the proportion
of GFAP immunoreactivity in human and rat neural progenitors (Bonni et al., 1997; Liu et al.,
2004; Weible and Chan-Ling, 2007). The data obtained in this study are consistent with previ-
ous observations, which together attribute the astroglial lineage commitment to the synergistic
effects of BMP4 and LIF.
LIF, a member of the interleukin-6 family acts through the gp130 signal transduction unit and is
referred to maintain the dividing hNP-AC in a proliferative state by preventing maturation and
differentiation into non astrocytic cells (Nakashima et al., 1999; Bonaguidi et al., 2005).
In the present study, progenitor cell characteristics in the hNP-AC were also maintained fol-
lowing exposure to BMP4 and LIF. The majority of hNP-AC, that migrated out of plated neu-
rospheres were immunoreactive for nestin (89 ± 2.3%), SOX2 (88.0 ± 3.6%) and Musashi-1
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(89.2± 3.8%). The RT-PCR showed no significant change of nestin- or CD133 mRNA in com-
parison to the non-differentiated hNPC populations. In this regard, the modification process
with BMP4 and LIF did not significantly alter the hNP-AC in respect to the hNPC phenotype.
However, a qualitative change in hNP-AC Musashi-1 immunoreactivity in comparison to hNPC
immunoreactivity was observed. The staining pattern changed to a more patchy illumination.
The relevance of this observation is not clear. Others also noticed an uneven distribution in
Musashi-1 immunoreactivity in neural stem/progenitor cells, and reported that Musashi-1 is
mainly localized in non-oligodendroglial progenitor cells (Kaneko et al., 2000).
BMP4, a member of the TGFβ superfamiliy, promotes differentiation in the direction of the
astrocytic lineage and inhibits oligodendrocyte or neuronal lineage development (Mabie et al.,
1997; Mehler et al., 1997, 2000; Zhang and Li, 2005). The present data confirm the elaboration
of the astrocytic lineage with an increased detection of GFAP- (92.5 ± 3.4%) and S100β im-
munoreactivity (79.4 ± 1.7%). In agreement, there was a significant increase of GFAP mRNA
as wells as CD44 mRNA in hNP-AC in comparison to hNPC.
Although the amount of S100β mRNA did not alter in hNP-AC (compared to hNPC), immuno-
cytochemistry revealed a significant increase in the number of S100β -positive cells. The altered
S100β staining pattern in hNP-AC contrasted to that in hNPC prior to differentiation It is likely,
that S100β remained associated to the intermediate filaments GFAP and vimentin (Sorci et al.,
1998), which were up-regulated due to BMP4 and LIF application. Thus, the up-regulation of
S100β protein and the altered staining pattern serve as an additional indicator for the intracel-
lular reorganisation that had occured during hNP-AC differentiation.
This study confirms, that the number of CD44 immunoreactive cells increased after application
of BMP4 (Liu et al., 2004). The GFAP immunoreactive cells (> 90%) all co-expressed CD44.
The increase of hNP-AC CD44 immunoreactivity is in agreement with the significant increase
of CD44 mRNA expression.
However, the generation of pure astrocytic aggregates, even after eight passages, was not pos-
sible in the present study. This is in contrast to reports by others, e.g. Weible and Chan-Ling
(2007). A small but constant sub-population of TuJ1- and MAP2ab-immunoreactive cells could
be identified in the monolayers of cells migrating from the PLL/laminin plated spheres. On
the other hand, in cryosections of hNP-AC-neurospheres no cells were labeled for the neuronal
markers anymore. One explanation might be that some hNP-AC showed spontaneous differen-
tiation, when they migrated on PLL/laminin substrate.
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In conclusion, the present investigation has shown that a highly enriched population of immature
astrocytes can be obtained by exposure of hNPC to BMP4 and LIF. These cells could be further
utilised for in vitro an in vivo studies to investigate their ability to support axon regeneration
and tissue repair in experimental SCI.
4.2 Proliferation of hNPC and hNP-AC
One of the first requirements in cell implantation strategies is the generation of usable quantities
of cells. Therefore, the extent to which hNPC differentiation to hNP-AC alters proliferation
kinetics was assessed.
4.2.1 Optimisation of Neurosphere Culture Conditions
The hNPC and hNP-AC were kept under proliferative conditions with the media supplements
B27, EGF and bFGF, which in combination have proven to optimise the proliferative activity of
cultured human foetal neural progenitor/stem cells (Svendsen et al., 1998; Wachs et al., 2003;
Kanemura et al., 2002; Mori et al., 2006; Weible and Chan-Ling, 2007). The amount of these
supplements remained constant throughout the differentiation process to exclude possible influ-
ences on cell expansion caused by culture medium composition.
The propagation of the hNPC and hNP-AC was promoted using the neurospheres culture tech-
nique. This technique was developed by Reynolds and Weiss (1996) in rodent neural stem/
progenitor cell cultures and has been applied in many studies for human neural progenitor/stem
cells. It has been suggested that the three dimensional architecture within the neurosphere cre-
ates a micro-environment that promotes proliferation of hNPC (Mori et al., 2006).
The passaging process of the neurospheres remains an important and critical parameter for cell
expansion, because the selected technique has an important influence on cell survival and pro-
liferation rates in human neural progenitor/stem cells. In the literature, a range of different
dissociation methods have been described, such as classical enzymatic dissociation techniques
using trypsin or the sectioning of spheres, also referred to as chopping (Svendsen et al., 1998).
The chopping method maintains the cell-cell interactions but cannot be used when single cell
suspensions are required. In contrast, enzymatic dissociation with trypsin generates a single
cell suspension, but results in a significant loss of cells (Svendsen et al., 1998; Wachs et al.,
2003). Thus, in the present study, the enzyme Accutase was used because it is regarded as a less
aggressive enzymatic dissociation technique (Svendsen et al., 1998; Wachs et al., 2003) and has
been proven to minimise cell loss during passaging and to achieve highest cell numbers.
Numerous studies have discussed the issue of how long human neural progenitor/stem cells can
72
4.2 Proliferation of hNPC and hNP-AC
be kept in culture conditions while maintaining their multipotency and proliferative states. In
contrast to rat neurospheres, human neurospheres derived from all regions of the CNS show
continual growth over the first 20 weeks of culture (Ostenfeld et al., 2002). Some groups report
that neurospheres derived from human foetal tissue could be expanded in long term cultures
for up to 6-8 months (Murray and Dubois-Dalcq, 1997; Kanemura et al., 2002) while others
have maintained stem/progenitor cells in neurosphere-cultures up to 1 year before proliferation
arrest was detected (Svendsen et al., 1999; Quinn et al., 1999). The fact that the cells under-
went senescence and stopped dividing is an important characteristic, indicating that the cells
had not oncogenically transformed in culture (Svendsen et al., 1999; Kanemura et al., 2002). In
agreement with the findings above, hNPC and hNP-AC of the present study could be kept in a
proliferative state for up to 6-8 months.
4.2.2 Methods to Assess Cell Proliferation
Traditionally, in vitro cell proliferation is determined directly by counting the cells. Although
this method is simple and inexpensive, it is necessary to break down the neurospheres enzymat-
ically to obtain a single cell suspension (Svendsen et al., 1997; Carpenter et al., 1999; Quinn
et al., 1999; Ostenfeld et al., 2002). Furthermore, this procedure is laborious and potentially
inaccurate, because of difficulties to dissociate the neurospheres into a complete single cell sus-
pension (Kanemura et al., 2002).
Therefore, both metabolic- and morphological assays were performed for the assessment of cell
numbers and proliferation of hNPC and hNP-AC.
In application of the metabolic assay with an indirect measurement of proliferative activity in
hNPC and hNP-AC some technical difficulties had to be faced: the CellTiter-Blue R© Reagent
is designed for use as an end-point assay rather than a kinetic method of monitoring cell growth
over a period of time (Promega, Technical Bulletin, 2006). Therefore, it was difficult to stan-
dardise the ideal seeding density of hNPC (or hNP-AC), for longer measuring periods (>6-9
days). The choice of too low cell densities slowed down the proliferation rate. In contrast, the
choice of too high cell densities resulted in the eventual formation of levels of metabolised indi-
cator dye (Resorufin) producing a too high fluorescence signal, that was out of the preliminary
adjusted gain. Furthermore, it was not possible to examine intact neurospheres due to the lack
of penetration of resazurin deep into the sphere-structures and the uncertainity of how easily the
fluorescence product (Resofurin) can diffuse out (see chapter 2.4). Therefore hNPC and hNP-
AC were examined as 2D monolayer cultures on PLL/laminin plated surface with the metabolic
assay.
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In contrast, the 3D morphological assay enabled assessment of proliferation in non-disrupted,
complete neurospheres. Despite this favourable advantage, it has to be mentioned that there
were some methodical restrictions: a problem concerning registration of diameter was the miss-
ing 3rd dimension of the neurospheres. In this study all data of diameters were based on two
dimensional measurement with light microscopy.
Furthermore, there was restriction to the size of spheres that could be analysed. The morpho-
logical assay could not be properly performed in spheres with a very small (< 50µm) or a very
large (> 800µm) diameter due to increasing measuring inaccuracy.
The requirement of a relatively homogenous neurosphere, composed of similar sized cells, rep-
resents a further limitation to the morphological assay (Hulspas and Quesenberry, 2000; Singec
et al., 2006). Thus, the variable cellular composition of neurospheres (Svendsen et al., 1999;
Bez et al., 2003) may not accurately reflect the precise proliferation activity, thereby represent-
ing an uncertainity in the sensitivity of the obtained results in the present study.
4.2.3 Proliferative Activity of hNPC and hNP-AC
The gradients of the standard curves that were generated in the metabolic assay from hNPC and
hNP-AC differed, revealing the different metabolic activity of both cell types for the indicator
dye, resazurin.
The sigmoid growth curve of hNPC in the metabolic assay (see chapter 3.2.1, Fig. 3.13A)
showed typical proliferative activity among the different phases of cell growth (see chapter
2.4.3): the classical phases of cell growth (i.e. log-, plateau- and decline phase) were also
present in hNP-AC. In the metabolic assay, logarithmic growth was only observed in the first
days in hNPC- or hNP-AC-monolayer cultures, when cell density and nutrient supply offered
ideal growing conditions, with a minimum DT of 1.68 days for hNPC and a minimum DT of
3.2 days for hNP-AC. When monolayer cultures reached confluency, growth became stationary
and proliferation stopped. Then, the multiplication rate continuously decreased even to negative
values (see chapter 3.2.1, Fig. 3.13B and chapter 3.4.1, Fig. 3.27B).
In contrast, in the morphological assay the hNPC-neurospheres and the hNP-AC-neurospheres
showed constant logarithmic growth over the complete measuring period (see chapter 3.2.2,
Fig. 3.14 and chapter 3.4.2, Fig. 3.28). It is likely, that the differing growth conditions in
the performed assays are responsible for the contrasting growth behaviours. The propagation
of cells with the neurosphere culture technique in the 3D morphological assay indicates less
restrictive growth than cells grown as monolayer cultures in the 2D metabolic assay.
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The arrest of proliferation in confluent monolayer cultures approximately two weeks following
seeding in the metabolic assay, indicates a growth inhibition due to the cell-cell contact in hNPC
as well as hNP-AC. The critical cell density, that turned the proliferating cells to the stationary
phase and later to cell loss differed in between the hNPC and hNP-AC with a less high peak cell
number in hNP-AC.
Furthermore, the DT in hNP-AC cultured as monolayers was significantly higher compared to
the DT for hNPC in the metabolic assay. In accordance, the doubling times from the morpho-
logical assay resulting from the intact neurospheres were higher for hNP-AC as well, answering
thereby the initial question, that the hNP-AC showed and altered decelerated proliferative ac-
tivity after differentiation and in vitro propagation.
As mentioned above, the proliferative activity of non-transformed cell lines declines over time
in vitro until eventually a finite lifespan is reached. The longer in vitro propagation in hNP-AC
might have influenced their longer duration of DT .
The obtained data from the morphological assay with a DT of 3.46 days for hNPC- and of
5.1 days for hNP-AC-neurospheres are consistent with data from proliferation studies in intact
neurospheres of other groups. Svendsen and colleagues reported about an overall growth rate
of approximately 4-5 days in foetal human neural progenitor/stem cells (Svendsen et al., 1998,
1999). Kanemura and colleagues provided detailed information on growth rates in neural pro-
genitor neurospheres derived from human foetal forebrain tissue of 7-8 gestational weeks with a
DT of 82h (= 3.4 days) in neurospheres after 100-200 days in vitro and about a DT of 104-126h
(= 4.3-5.35 days) in long term cultures, i.e. > 200 days (Kanemura et al. (2002)).
The present investigation was unable to establish a correlation between DT , i.e. r, neither in
relation to the volume of spheres nor in relation to the time point investigated in the exper-
iment. This is in contrast with Mori and colleagues, who reported a dependency of DT on
hNPC-neurosphere volume for human foetus-derived tissue: They described an acceleration of
proliferation related to diameter increases of up to 250µm, which was mainly caused by the
aggregation of small neurospheres to larger ones (Mori et al., 2006). However, in the present
study the parameter of self aggregation could not exert any influence on apparent proliferative
activity, since spheres were cultured individually.
It has been suggested that the ability of nutrients and oxygen to diffuse to the hypoxic cen-
tral regions of large neurospheres may result in slowed growth rates (Svendsen et al., 1999).
However, BrdU- and Ki67-labeled cells have been found in central and peripheral regions of
neurospheres (up to 350µm; Mori et al., 2005, 2006). The present study confirms the presence
of proliferative, Ki67-positive, cells in the core as well as at the margin of the hNPC-and hNP-
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AC neurospheres with a range of sizes (up to 500µm). Therefore the notion that the inner part
of human neurospheres is unsuitable for the survival and proliferation of neural stem/progenitor
cells is, according to the present data, unfounded.
4.3 Conclusions
The investigation shows that hNPC from first-trimester human foetal forebrain and the resulting
differentiated hNP-AC show diversity in cellular composition and proliferation kinetics. The in-
vestigation was successful in a number of aspects:
I) The heterogeneous source of hNPC was better defined, confirming the presence of
non-committed cells at varying stages of development with a spontaneous differentiation
capacity to glial- and neuronal cell populations but not to an oligodendroglial cell lineage.
II) The hNPC were successfully differentiated, showing significant upregulation of astrocyte-
related markers, and were thereby termed hNP-AC. They represented a highly enriched
population of astrocytes, which still possessed stem/progenitor cell characteristics.
III) The proliferative activity was assessed with both a 2D metabolic and a 3D morpholog-
ical assay showing a deceleration in hNP-AC compared to hNPC prior to differentiation.
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Part II
Effects of Released Factors and ECM on
Neurite Regeneration in Vitro

5 Material and Methods
To better understand the mechanisms by which hMSC and hNP-AC supported neurite regen-
eration in adult rat DRG neurons as in an in vitro model for axon regeneration (Fu¨hrmann
et al., 2010a,b), the possible contributions of released trophic factors (i.e. present in condi-
tioned medium) or substrate-mediated mechanisms (via the ECM) were investigated.
5.1 Cultivation of hNP-AC and hMSC
For generation of hNP-AC derived ECM and conditioned media the hNP-AC were cultured as
monolayers as described in Part A (see chapter 2.1.1). The production of the ECM substrate
and the conditioned media will be described in the following (see chapter 5.2 and 5.3).
hMSC were kindly provided by K. Montzka (Clinic for Urology, University Hospital Aachen)
and had been isolated from bone marrow aspirates from patients during surgery following in-
formed consent, approved by the Ethical Committee of the University Hospital, Aachen. Char-
acterisation of isolated hMSC was performed by K. Montzka using three criteria i) adherence to
tissue culture plastic, ii) specific surface antigen expression, and iii) multipotent differentiation
potential (Prockop, 1997; Dominici et al., 2006; Montzka et al., 2009). hMSC were cultured as
monolayer cultures with the culture medium consisting of:
Panserin 401 medium supplemented with 2% FCS (Biowest, Nuaille, France),
EGF (10 ng/ml, Cell Concepts, Umkirch),
bFGF (1 ng/ml, Cell Concepts, Umkirch),
plateled derived growth factor BB (PDGF-BB; 1 ng/ml, Cell Concepts, Umkirch),
and 10nM dexamethasone (10 nM, Cell Concepts, Umkirch).
Media exchange was performed every 3-4 days until cells reached confluence. For passaging,
the cells were detached with trypsin/EDTA solution (Lonza, Vervieres, Belgium) and re-seeded
with a density of 4000 cells/cm2.
5 Material and Methods
5.2 Conditioned Media
To study the influence of trophic factors released from hNP-AC or hMSC to promote neural
outgrowth in vitro, DRG culture media (DRGM) was conditioned before application to DRG
neurons. DRGM was conditioned for 3 days by substances released from hNP-AC monolayer
cultures or from hMSC monolayer cultures. DRGM was provided to monolayers of each cell
type and consisted of:
48ml Neurobasal-A (Invitrogen),
1ml B27 1x (Stock 50x; Invitrogen),
0.5ml Glutamax (Invitrogen),
and 0.5ml Penicillin/Streptomycin (1:100 vol/vol, PAA).
The conditioned DRGM was termed hMSC- conditioned media (hMSC-M) or hNP-AC-con-
ditioned media (hNP-AC-M) and stored at 4◦C. The conditioned media was applied to DRG
neurons within 48 hours.
5.3 ECM Substrates
ECM-coated tissue culture dishes were produced as bio-substrates from hMSC (hMSC ECM)
and from hNP-AC (hNP-AC ECM) according to a published protocol (Milner and Campbell,
2002). The hNP-AC and the hMSC were plated on to PLL (0.01%) and laminin (5µg/ml) coated
cell culture 12-well plates (see chapter 2.1.1). Cells were grown as monolayer cultures for a
duration of 3-4 weeks and medium was changed every 3-4 days. One week after monolayer
cultures reached confluency cells were lysed by exposure to sterile water for 10 minutes as
described previously (Milner and Campbell, 2002). Three washing steps with sterile 0.1M PBS
were performed to remove cell debris and leave only adherent ECM on the tissue culture plates.
The next day, a DRG-suspension of highly enriched DRG neurons (400-500 neurons/ml) was
seeded on to the tissue culture 12-well plates, either covered with hMSC ECM or with hNP-AC
ECM as substrate. The PLL/laminin coating alone served as positive control substrate.
5.4 Dissection and Dissociation of Adult Rat DRG Neurons
Adult Lewis female rats served as donor experimental animals for the DRG neurons. The
dissections were performed by T. Fu¨hrmann (Institute of Neuropathology, University Hospital
Aachen) in accordance with the local animal ethics committee.
Under terminal isoflurane (Isofluran R©, Abott GmbH, Wiesbaden) anaesthesia, animals were
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rapidly decapitated. To extract the vertebral column, skin as well as back muscles were removed
and ribs were cut on each side. The vertebral column was cut transversely to generate 3 equal
sized pieces and opened along the anterior-posterior plane, thus preventing accidental damage
to the laterally positioned DRG. The opened pieces of spinal cord column and cord were placed
into cold Hanks’ balanced salt solution (HBSS; Invitrogen) and remnants of the spinal cord
and the dura were removed under the dissecting microscope. The DRG neurons were gently
removed using microsurgical tweezers and as much peripheral nerve as possible was cut away
with a surgical blade (Bean, 1990; Huettner, 1990).
The freshly dissected DRG neurons in HBSS were centrifuged at 1500rpm for 2 minutes to
sediment pieces. Ganglia were then incubated in collagenase buffer (100mM HEPES, 120mM
NaCl, 50mM KCl, 1mM CaCl2 and 5mM glucose, pH 7.4) containing 0.8% w/v collagenase
(CLS I, Biochrom AG, Berlin), and 3% w/v bovine serum albumine (BSA, fraction 5, Serva,
Heidelberg) for 2 hours in a shaking incubator at 37◦C. After the first enzymatic incubation,
trypsin (0.5ml, 0.25%, Invitrogen) was added for a further digestion of 30 minutes. To stop the
reaction, foetal calf serum (FCS, 0.5ml, PAA) was added and the mixture was centrifuged for 3
minutes at 2000rpm. The supernatant was aspirated and replaced by 1.5ml of DRGM.
The suspension was gently dissociated by trituration with a pipette 10-15 times. After 5 minutes,
the supernatant was pipetted into a separate falcon tube and 1ml of fresh DRGM was added
and the dissociation was repeated. A small volume (approx. 2ml) of Percoll density gradient
solution (1.3ml Percoll, Amersham; 450µl 0.1M PBS; 3.2ml a.d.) was carefully added to the
bottom of the DRG neuron solution and the suspension was centrifuged at 2500rpm for 10
minutes. The supernatant was removed and the residual pellet of neurons resuspended, either
in DRGM or alternatively in the conditioned hMSC-M or hNP-AC-M. The DRG neurons were
either applied to the cell-free ECM substrate of hNP-AC or hMSC or alternatively plated on to
the positive control PLL/laminin substrate.
5.5 Experimental Test Conditions and Microscopy
For each experiment DRG neurons from at least 2 different donor animals were examined. As
a positive control, dissociated DRG neurons were resuspended in non-conditioned DRGM and
seeded on to PLL/laminin substrate, which is known to support neuronal adhesion and axon
regrowth (Manthorpe et al., 1983; Lander et al., 1985; Lander, 1987; Tonge et al., 1997). After
24 hours DRG neurons were fixed with 4% PFA for 30 minutes. On regrowing DRG neurites
and cell bodies immunocytochemistry was performed with a mixture of monoclonal anti-NF200
antibody (200kDa, NE14, Sigma) and monoclonal anti-MAP2ab antibody (Sigma) as described
in Part A (see chapter 2.2). DRG neurons were visualised using an inverted Zeiss Axioplan
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epifluorescence microscope coupled to an on-line digital camera (Axiovision software). Data
files documenting extensive neurite outgrowth reaching over several images were merged with
Adobe Photoshop Software CS2.
Figure 5.1 demonstrates the different experimental conditions, to which the regenerating DRG
neurons were subjected.
Figure 5.1: Schematic drawing of the different experimental conditions resulting from the change of the
ECM substrate and culture media for regenerating adult rat DRG.
The DRG axon regeneration was investigated in the presence of the different ECM substrates (see left
side) in combination with the applied culture media (see right side). The ECM substrate derived from
hNP-AC (hNP-AC ECM, grey) and the ECM derived from hMSC (hMSC ECM, black) was studied to
determine their ability to support axon regeneration by adult DRG neurons. The PLL/laminin coating
(white) served as a positive control substrate. The applied culture media for the regenerating DRG
neurons had been previously conditioned either by hNP-AC (hNP-AC-M) or by hMSC (hMSC-M).
With this experimental approach, the effects on DRG neuron regeneration through trophic factor release
and substrate-bound mechanisms were investigated. Non-conditioned DRGM served as media control.
5.6 Evaluation of Axon Regeneration by Adult Rat DRG
For each experimental condition 50 DRG neurons per donor animal were selected by the fol-
lowing criteria: (i) growth from solitary, well spaced out neurons, (ii) not located at the edge of
a 12-well plate and (iii) clear identification of neurites belonging to one DRG soma.
Fluorescence microscopy images of neurites (e.g. Fig. 5.2A) were manually traced in Adobe
Photoshop software using a graphics tablet (Intuus R©, Wacom). Brush diameter was adjusted
to 6 pixels. The cell soma was not traced. A threshold level value of 170 was set while con-
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verting images to black and white (Fig. 5.2B). Any remaining staining artefacts were manually
removed and threshold level adjusted to optimise uniformity of illumination and contrast as de-
scribed previously (Pool et al., 2008).
After this manual pre-processing, images were transformed with Image J Software 1.38d. Im-
ages had to undergo a threshold level adjustment again, since 8-bit binary images were required
for further processing (Fig. 5.2C). The remaining image information was processed with the
”Skelettonization” function which reduced the axonal profiles to single pixel thickness (Fig.
5.2C, red box). The amount of pixels quantified reflected the total neurite outgrowth of each
individual DRG neuron.
5.7 Statistical Analysis of DRG Neurite Outgrowth
In this study 800 DRG neurons were traced and analysed. Data were plotted as mean values
± SEM representing averages of experimental conditions performed in duplicate. All analysed
data (i.e. total neurite outgrowth, maximal neuritic vector and number of primary neurites) was
standardised in relation to the values generated on the PLL/laminin positive control substrate
with DRGM as control culture medium.
Data was subjected to an analysis of variance (ANOVA) followed by Bonferrroni’s test for
multiple comparisons between pairs of means. P values of < 0.05 were regarded as significant
(i.e. * p < 0.05, ** p < 0.01, *** p < 0.001). All tests were performed using the statistical
software Graph Pad Prism 4.0.
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A: The image shows a sample of a rat
DRG neuron on PLL/laminin control
substrate and DRGM as control culture
media. Regenerating neurites were
stained with a combination of anti-
MAP2ab antibody (red) and anti-NF200
antibody (red).
B: The neurites were traced (white)
with a brush tool and the red signal was
discarded.
C: The thresholded images were ”skele-
tonized” with Image J software. The
amount of ”skeletonized” neurites was
estimated by total pixel counts. A magni-
fication of skeletons is shown in the red
box.
Figure 5.2: Quantification of regenerating neurites by digital processing and neurite tracing.
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In an attempt to better understand the beneficial interactions of stem/progenitor cells with re-
generating neurites our group has studied the axon growth promoting effects of hMSC- and
hNP-AC monolayers in vitro with dissociated adult rat DRG neurites as model of repair af-
ter CNS injury (Fu¨hrmann et al., 2010a,b). The mechanisms by which hMSC and hNP-AC
supported neurite regeneration remained unclear. Therefore, the influence of released trophic
factors (i.e. conditioned media) or substrate-mediated mechanisms (i.e. the ECM) of hMSC
and hNP-AC and their possible interactions to modify DRG neurite regeneration in vitro were
investigated in the present study.
6.1 ECM Substrates derived from hNP-AC or hMSC
Figure 6.1: Confluent monolayers of hNP-AC and hMSC.
A: A confluent monolayer of hNP-AC is stained with antibodies to GFAP (green) and vimentin (red)
visualising a densely packed network of cells. B: A phase contrast image of viable hMSC in culture
demonstrates their elongated cell bodies as they approach confluence. The hMSC also show an aligned
arrangement.
The ECM substrates were generated from hNP-AC (Fig. 6.1A) and hMSC (Fig. 6.1B), which
had established densely packed, confluent monolayers. Several GFAP- and vimentin-positive
hNP-AC showed astrocytic polymorphic or ”fried egg”-shaped morphologies with diameters
ranging from 30-80µm. The hMSC adhered to the tissue culture plastic and upon becoming
confluent, adopted extended cell bodies which often ran in parallel with each other.
6 Results
6.1.1 Quantification and Morphology of DRG Neurons
Figure 6.2: Highest overall neurite outgrowth promoted by hNP-AC ECM.
A-C: Examples of typical DRG neurons on the different ECM substrates. Neurons were combinatory
stained for NF200 and MAP2ab (red). The DRG neurons show regeneration on all substrates:
(A) PLL/laminin, (B) ECM of hNP-AC and (C) ECM of hMSC.
D: The histogram shows the overall neurite outgrowth on the different ECM substrates standardised to
the PLL/laminin control substrate. All pairs of columns differed significantly from each other (∗∗∗, p
< 0.001). The overall neurite outgrowth was greatest on hNP-AC ECM substrate, and that measured
on PLL/laminin was greater than on hMSC ECM substrate. Data represent means ± SEM; n = 100.
NF200/MAP2ab-positive regenerating neurites were detected on all substrates. In Figure 6.2
examples of DRG neurite regeneration over the PLL/laminin positive control (Fig. 6.2A), for
hNP-AC ECM (Fig. 6.2B) and for hMSC ECM (Fig. 6.2C) are shown. To prevent a poten-
tial bias concerning the quality of the DRG dissociation on the subsequent analysis of DRG-
substrate or DRG-media interactions, all data of neuritic regeneration was standardised to the
PLL/laminin positive control substrate with control media (DRGM, Fig. 6.2A). Thus, data of
neurite outgrowth (x) are not demonstrated as absolute values [µm], but presented as a ratio
to the appropriate positive control value (i.e. ratio of x / (PLL/laminin with DRGM)). A table
listing the standardised relative data used for analysis and the absolute values [µm] for all ex-
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perimental conditions is attached in the appendix (see additional data, Table 9.4).
The dissociated DRG neurons rapidly attached to the test substrates and demonstrated round
cell bodies (measuring 55 ± 6µm in diameter), from which multiple regenerating neuritic pro-
cesses extended in all directions. The regenerating neurites often achieved substantial growth
and complex aborisation patterns. Observation of growth over the PLL/laminin positive control
substrate confirmed that the DRG dissociation had generated a highly enriched population of
DRG neurons, with relatively little glial contamination (Delree et al., 1989; Schoenen et al.,
1989).
Neurite regeneration on the PLL/laminin-coated substrate (Fig. 6.2A) appeared uniform in all
directions, generating a radial growth pattern of robust primary processes, which showed mul-
tiple branching points. Regeneration of DRG neurites on hNP-AC ECM (Fig. 6.2B) showed a
similar growth pattern with multiple radial sprouting processes, that seemed to be more exten-
sive than on the control substrate. The greater overall dimension and expansion of the neuritic
outgrowth on hNP-AC ECM was most striking (compare the different scale bars in Fig. 6.2A
and B). Neurite regeneration over hMSC-ECM also showed a radial growth pattern, but the
sprouting processes appeared to be shorter with fewer branching points (Fig. 6.2C).
6.1.2 Total and Longest Neurite Length
For quantification and comparison of the potential of the different substrates to promote neu-
rite outgrowth, the length of all neurites was summed and represented the value of total neurite
length per substrate (Fig. 6.2D). Statistical analysis showed that total neurite length on all three
substrates differed significantly from each other (Fig. 6.2D, p < 0.001).
Whereas the overall DRG neurite outgrowth on hMSC ECM substrate was significantly (p <
0.001) lower than that on the PLL/laminin positive control, the neurite outgrowth measured on
the hNP-AC ECM substrate was the greatest of all (p < 0.001).
To compare the maximal neurite outgrowth distance of DRG neurons on the different substrates,
the length of the vectors between the cell soma and the tip of the longest NF200/MAP2ab-
immunoreactive neurite was measured (Fig. 6.3B). Similar to the quantification for total neurite
length, the values obtained were expressed as a ratio in comparison to the mean longest vector
measured over the PLL/laminin control substrate. Statistical analysis showed a significant dif-
ference between the mean longest neurite length of the three experimental groups (Fig. 6.3A)
with the longest neuritic vectors being recorded over the hNP-AC ECM substrate. The shortest
neuritic vectors were found over the hMSC ECM substrate. The level of significance however
was less strong (Fig.6.3A, p < 0.01) in the investigation concerning the data of the longest
neurite length compared to the data of overall neurite outgrowth (Fig. 6.2D, p < 0.001).
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The term primary neurite describes branches of neurites that sprout directly out of the DRG
neuron cell soma (Fig. 6.3D). There was no apparent difference in the number of primary neu-
rites supported by either hMSC ECM, hNP-AC ECM or the PLL/laminin control substrate (Fig.
6.3C).
Figure 6.3: Maximum vectors of neurite length and elaboration of primary neurites on different substrates.
A: The graph shows a histogram summing the longest neurite length in DRG neurons for all three sub-
strate conditions standardised to the PLL/laminin control. There is a statistically significant difference
between all pairs of columns. The significantly longest neurite vectors are promoted on hNP-AC ECM
substrate compared to PLL/laminin (∗∗ p < 0.01) and hMSC ECM substrate (∗∗∗ p < 0.001).
B: A DRG neuron is shown on PLL/laminin substrate with DRGM combinatory stained for NF200 and
MAP2ab (red). The white line demonstrates the vector of the longest neurite length of the DRG neuron.
C: There was no difference in development of primary branches in variation of the ECM substrate.
D: A representative DRG neuron is combinatory stained for NF200 and MAP2ab (red). The white cir-
cles point out the primary neurite branches sprouting out of the DRG cell soma. Data represent means
± SEM; n = 100.
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6.2 Effects of Released Factors from hNP-AC or hMSC
Experimental manipulations with conditioned media of hMSC or hNP-AC resulted in regener-
ating DRG neurons with a complex and highly subdividing neurite architecture. Especially, the
group of DRG neurons treated with hNP-AC-M (Fig. 6.5D) showed profuse and wide spread
neurite expansion compared to the DRGM control group (compare the different diameters of
regenerating DRG, Fig. 6.5C and D).
6.2.1 Total and Longest Neurite Length
The DRG neurons treated with conditioned media either from hMSC or hNP-AC showed sig-
nificantly (p < 0.001) greater total neurite outgrowth than those from the control group which
received unconditioned DRGM (Fig. 6.5A). There was a tendency for a lower extend of overall
neurite outgrowth from neurons cultured with hMSC-M compared to those cultured in hNP-
AC-M (Fig. 6.5A); however the values failed to reach the level of statistical significance.
The investigation of the vector of the longest neurite per DRG neuron (Fig. 6.5B) revealed that
hNP-AC-M induced a significant increase (p < 0.01), when compared to DRGM or hMSC-M.
Apparently, hMSC-M had no significant effect on this value.
The investigation concerning the elaboration of primary neurites in between the different media
applications showed no significant differences (Fig. 6.4). There was only a slight tendency for
more primary neurites to be generated by conditioned media from hMSC-M or hNP-AC-M,
however the values did not reach the level of statistical significance (Fig. 6.4).
Figure 6.4: Elaboration of primary neurites in DRG neurons, when cultured with different media.
There was no significant difference in elaboration of primary neurites under any of the experimental
conditions. Data represent means ± SEM, n = 100-200.
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Figure 6.5: hMSC-M and hNP-AC-M strongly support neurite outgrowth and length of longest neurite.
A: Conditioned media of hMSC or hNP-AC promote total neurite outgrowth significantly greater than
that seen with the comtrol DRGM. B: Analysis of the vector for longest neurite length revealed that
hNP-AC-M had the greatest effect, whereas hMSC-M apparently had no significant effect on this pa-
rameter in comparison to DRGM control. Data represent means ± SEM; n = 100, *** p < 0.001; **
p < 0.01. C-D: Representative DRG neurons combinatory stained for NF200 and MAP2ab (red) were
treated with unconditioned DRGM as control medium (C) or conditioned hNP-AC-M (D). The DRG
neurons cultured with hNP-AC-M show a wide spread neurite expansion and complex growth pattern.
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6.3 Interactions of Trophic Factors and ECM Substrate
The question remained, to what extent the neuronal responses to diffusible trophic factors (i.e.
present in conditioned medium) could be modified by interactions with its environment (i.e.
the extracellular matrix). Similarly, to what extent are the responses of the cell to its ECM
environment modified by the presence of diffusible trophic factors. This issue was addressed
by using combinations of cell-derived ECM substrate and conditioned media obtained from
hNP-AC and hMSC. Two major experimental conditions were tested:
I) a combination of hNP-AC ECM with hMSC-M and
II) a combination of hMSC ECM with hNP-AC-M.
These combinations were compared with the effects of either the relevant ECM or conditioned
medium applied individually to regenerating neurites.
There was a strong overall neurite outgrowth detectable, when the first combination (hNP-AC
ECM and hMSC-M) was applied to the DRG neurons. The combination lead to a significantly
(p < 0.001) higher promotion of neurite regeneration compared to the PLL/laminin control
substrate with DRGM control media. Furthermore, the combination proved to stimulate signifi-
cantly (p < 0.05) more overall neurite outgrowth than hNP-AC ECM individually with DRGM
control or hMSC-M individually with PLL/laminin control substrate (Fig. 6.6A). Likewise, the
investigation for the vector of the longest neurite length showed, that the combination of hNP-
AC ECM with hMSC-M supported strong neurite regeneration. This combination supported the
elaboration of significantly longer neurites compared to the control group as well as to exposure
to hMSC-M alone (Fig. 6.6A). However, there was no significant difference in the value for the
vector of the longest neurite length in between the combination (hNP-AC ECM and hMSC-M)
compared to hNP-AC-ECM individually (Fig. 6.6B).
The elaboration of the number of primary neurites per neuronal cell body seemed not to be
influenced by the combinatory approach (data not shown).
The second combination (hMSC ECM and hNP-AC-M) showed very little overall neurite out-
growth of DRG neurons (Fig. 6.6C). The neurites extended to a lesser degree than over the
PLL/laminin plus DRGM control condition. The same behaviour was true when the vector for
the longest neurite length was investigated (Fig. 6.6D). The total neurite outgrowth (Fig. 6.6C)
as well as the length of the longest neurite (Fig. 6.6D) of the combination, containing hMSC
ECM and hNP-AC-M, lay significantly (p< 0.001) beneath the values of the control group and
the individual application of hNP-AC-M to DRG growing on the PLL/laminin control substrate.
The elaboration of the number of primary neurites from the neuronal cell body seemed to be
unaffected by the combinatory approach (data not shown).
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Figure 6.6: Combinatory application of conditioned media and ECM, investigating interactions on neurite
regeneration.
A-B: A combination of hNP-AC ECM with hMSC-M (columns with vertical stripes in A and B) shows
significantly greatest overall neurite outgrowth (A) and longest neurite length (B). The data of hNP-AC
ECM (grey columns) and hMSC-M (black columns) have been described before in chapter 6.1 and 6.2.
C-D: The combination of hMSC ECM with hNP-AC-M (columns with horizontal stripes in C and D)
shows overall neurite outgrowth (C) and longest neurite length (D), which is significantly smaller than
the PLL/laminin control and the individual application of hNP-AC-M to DRG neurons. The data of
hNP-AC-M (grey columns) and hMSC ECM (black columns) have been described before in chapter
6.1 and 6.2. Data represent means ± SEM, n = 100, * p < 0.05, ** p < 0.01, *** p < 0.001.
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6.4 Summary
In the present study, the potential of ECM and conditioned media derived from hNP-AC or
hMSC to promote regeneration in adult DRG neurons was investigated. When ECM substrate
was varied, DRG neuron regeneration with greatest neurite outgrowth was found on hNP-AC
ECM (Fig. 6.7, 2nd column), which was significantly greater compared to the PLL/laminin con-
trol or the hMSC ECM substrate (Fig. 6.7, 3rd column). Investigations concerning the variation
of media showed, that hNP-AC-M (Fig. 6.7, 5th column) as well as hMSC-M (Fig. 6.7, 6th
column) promoted significantly higher neurite outgrowth than the DRGM control media. The
combination of hNP-AC ECM and hMSC-M (Fig. 6.7, 8th column) to test possible interactions
of trophic factors (i.e. conditioned media) and their environment (i.e ECM) provided maximum
neurite outgrowth together with hNP-AC-M on PLL/laminin control substrate (Fig. 6.7, 5th col-
umn). Surprisingly, the combination of hMSC-ECM with hNP-AC-M provided relatively poor
neurite outgrowth (Fig. 6.7, 9th column).
Figure 6.7: Neurite outgrowth of DRG neurons for all experimental condtions.
The first three columns show the overall neurite outgrowth of DRG neurons, when ECM substrate
was varied. The next three columns represent the overall outgrowth, when media was varied, and the
columns on the right show the overall outgrowth, when both parameters were varied.
Constant parameters were unconditioned DRGM as media in the first three columns and PLL/laminin
substrate in the center columns. All data represent means ± SEM. The data of the different exper-
imental runs can be compared, because they represent relative values, standardised to their control
(PLL/laminin and DRGM with a relative value of 1.0). Absolute values [µm] for all experimental
conditions are attached in the appendix (see additional data, Table 9.4).
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7 Discussion
The role of cell-substrate interactions regulating neurite regeneration and outgrowth both in
vitro and in vivo has been a subject of intensive study during the last decades. Recently the
emphasis of cellular substrates for inducing CNS or PNS axon growth has shifted from that
supported by populations of tissue cultured primary glia (Noble et al., 1984, 1985; Smith et al.,
1986, 1990) to that supported by stem/progenitor cells, including embryo-derived (McDon-
ald et al., 1999), foetal-derived or adult-derived neural stem/progenitors cells (Ogawa et al.,
2002; Pfeifer et al., 2004), as well as by non-neural mesenchymal stromal cells (Chopp et al.,
2000; Deng et al., 2006). In an attempt to better understand the beneficial interactions of
stem/progenitor cells with regenerating neurites, our group has studied the axon growth pro-
moting effects of hMSC and hNP-AC monolayers on neurite regeneration from dissociated
adult rat DRG in vitro (Fu¨hrmann et al., 2010a,b). Since the mechanisms by which hMSC and
hNP-AC supported neurite regeneration remained poorly defined, the possible contributions of
trophic factors (i.e released into conditioned medium) and substrate-mediated mechanisms (i.e.
the ECM) have been investigated.
The present data supported the hypothesis that the ECM of hNP-AC is an important compo-
nent for supporting strong neurite regeneration in vitro. Furthermore, the data indicated that
diffusible trophic factors released by hNP-AC were also important for supporting strong neurite
regeneration when DRG were seeded on to the control, PLL/laminin substrate (see section 7.3).
In contrast and somewhat surprisingly, the major contributor to hMSC-mediated axon growth
appeared to be provided by the trophic factors released from these cells, with the hMSC ECM
being a relatively poor substrate for axon regeneration (see section 7.4).
Finally the question remained to what extent neuronal responses to diffusible trophic factors
(i.e. present in conditioned medium) could be modified by interactions with its environment
(i.e. the ECM). The combinatory application of hNP-AC ECM with hMSC-M induced the
greatest degree of axonal outgrowth in the present study. However, the potent axon growth pro-
moting effects of hNP-AC-M were found to be incapable of enhancing neurite extension over
the hMSC ECM (see section 7.5).
7 Discussion
7.1 DRG Neurons as an Experimental Model for Axon
Regeneration
Adult rat DRG neurons were used as the model population for axon regeneration. They transmit
a range of sensory information to the CNS including the sensory modalities of proprioception,
thermoception and nociception. There are several reasons, why adult DRG neurons served as
an ideal test neuron for such studies in vitro:
I) DRG neurons extend axonal projections into both CNS and PNS and would therefore
be involved in injury to both types of nervous tissue (Golding et al., 1996, 1999),
II) DRG neurons are readily accessible, being rapidly dissected from the spinal columns
of experimental animals,
III) an enrichment protocol for these neurons has already been developed (Delree et al.,
1989), thereby avoiding complications of interpretation that often arise when using DRG
explants (Wright et al., 2007),
IV) freshly dissected and dissociated adult DRG are able to survive and regenerate axons,
in contrast to neurons from the adult CNS, that do not survive after dissociation (Bjo¨rk-
lund and Stenevi, 1984),
V) adult DRG neurons may be more appropriate than embryonic neurons for such studies
because developmental changes in the sensitivity of neurons to signals from their envi-
ronment have been reported (Fawcett et al., 1989),
VI) DRG neurons have already been used in numerous in vitro and in vivo axon growth
and regeneration studies (Schwab and Caroni, 1988; Davies et al., 1997, 1999; Chen et al.,
2000b).
The neurite lengths from these dissociated neurons were assessed by a computer assisted semi
automatic manner to assure accuracy as well as simplicity of approach and because other
groups had previously reported that the full automatisation of the procedure was difficult, time-
consuming and not completely reliable (Pool et al., 2008).
In the present investigation, no attempt was made to separate the dissociated DRG into their well
documented 3 general sub-types. These sub-types have been described as (i) large-to-medium
diameter NF200-positive/neurotrophin responsive neurons, (ii) small diameter calcitonin gene
related peptide (CGRP)-positive/neurotrophin responsive neurons and (iii) small diameter lectin
binding immunoreactive (IB4+)/glial cell-derived neurotrophic (GDNF) factor responsive neu-
rons (Priestley et al., 2002). It has recently been shown that adult rat DRG neuronal sub-types
display different signalling requirements for axonal regeneration (Tucker et al., 2006). Fur-
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thermore, the IB4-positive small diameter neurons have been reported to be unresponsive or
minimally responsive to ECM signals related to PNS tissues (e.g. laminin, collagen IV and
fibronectin), however, such ECM signal are required for the neurons to be able to respond to
GDNF (Molliver et al., 1997; Bennett et al., 1998; Kashiba et al., 2001). The NF200-positive
and the CGRP-positive neurons, on the other hand, do respond to such ECM or growth fac-
tors signals by generating axons and the combined effect of ECM (i.e. laminin) plus growth
factor (i.e. NGF) stimulation supported even greater axon growth (Jones et al., 2003b; Tucker
et al., 2006). It might be argued that, for some reason, the failure to demonstrate extensive
neurite outgrowth over hMSC ECM in the present investigation may have been due to a tech-
nical problem of somehow only harvesting the IB4-positive sub-populations of neurons. This
is, however, most improbable because the immunocytochemical detection of cell bodies and
neurites included the use of NF200-staining confirming the presence of the large diameter NF-
positive/neurotrophin responsive sub-type of neurons.
7.2 Neurite Outgrowth on ECM Substrates
An in vitro model was required to investigate the influence of hNP-AC- and hMSC-derived
ECM on neurite regeneration. The ECM from confluent hNP-AC and hMSC was presented as
a substrate for neuron attachment and axon extension on the floor of the tissue culture wells.
The ECM from a range of cell types including skeletal muscle cell myotubes (Tomaselli et al.,
1986; Bixby et al., 1987), Schwann cells (Tomaselli et al., 1986), astrocytes (Freire et al., 2004;
Neugebauer et al., 1988) and olfactory ensheathing cells (Tisay and Key, 1999) has been pre-
pared for similar cell-substrate investigations in vitro. The ECM produced by these cells has
been shown to have a pronounced effect on neuronal morphogenesis, guidance and regenera-
tion.
Several methods for the preparation of ECM from confluent cell monolayers have been de-
scribed, such as chemical cell lysis with ethylene glycol tetraacetic acid (EGTA; Blenis and
Hawkes, 1983; Leco et al., 1994), ethylendiaminetetraacetic acid (EDTA; Fairbairn et al., 1985;
Wu et al., 1997), ammonium hydroxide (Niedbala et al., 1986; Rebaı¨ et al., 2005), Triton X-
100 (Carter et al., 1990) and the application of paracetic acid with freeze drying (Santucci and
Barber, 2005). These rather aggressive procedures often required addition of protective compo-
nents (protease inhibitors, buffer substances, dehydrating factors etc.) to keep the ECM intact
(Hedman et al., 1979; Carter et al., 1990; Santucci and Barber, 2005). Alternatively, ECM has
also been prepared by cell lysis provoked by incubation with sterile water for 10 minutes and
ongoing washing steps in cold 0.1M PBS to remove cell debris and reduce the activity of re-
leased enzymes, thereby preventing the application of protease inhibitors. This method was
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applied in the present study for several reasons:
I) it seemed to be a less aggressive approach for the preservation of the ECM framework,
II) the protocol had already been established being simple to follow (Lider et al., 1995;
Doss, 1999),
III) the protocol had already been applied to astrocytic cells (Milner and Campbell, 2002).
The lysis of confluent hNP-AC and hMSC monolayers with water provided satisfactory results:
after washing steps there were no large remnants of cell debris that could be detected by light
microscopy, indicating the total removal of viable cells.
7.3 Support of Neurite Outgrowth by hNP-AC ECM and hNP-AC-M
The present study demonstrates that neurite outgrowth over hNP-AC ECM was significantly
greater than that seen over the PLL/laminin positive control substrate (p < 0.001). Similarly
strong neurite outgrowth was supported by viable monolayers of hNP-AC in comparison to the
PLL/laminin substrate (p< 0.001). The greatest overall neurite outgrowth over the PLL/laminin
substrate was supported by hNP-AC-M, however this effect failed to reach the level of statis-
tical significance when compared to viable hNP-AC monolayers or hNP-AC-ECM (Fig. 7.1A,
compare 2nd , 4th, 5th and 8th column; data for viable cell monolayers were kindly provided
by T. Fu¨hrmann and K. Montzka). This confirmed the hypothesis that both diffusible trophic
factors (i.e. present in conditioned medium) and ECM-related mechanisms contributed to hNP-
AC-mediated support of axon regeneration.
These findings relate to the concept that immature astrocytes play an essential role in ax-
onal growth in the developing CNS and also in CNS regeneration via the expression of ECM
molecules supportive for axon extension, and by releasing trophic factors into their environ-
ment (Noble et al., 1984; Smith et al., 1986, 1990; Silver, 1988; Davies et al., 1997; Biran et al.,
2003; Tom et al., 2004; Freire et al., 2004; Chow et al., 2007). It has been reported that cer-
tain growth factors (including bFGF, EGF and TGF) as well as neurotrophins (including NGF,
BDNF and NT-3) are secreted by astrocytes and play an important role in CNS development
and in CNS regeneration following injury in vitro and in vivo (Giulian et al., 1993; Kane et al.,
1996; Kuhn et al., 1997; White et al., 2008; Delgado-Rivera et al., 2009). The expression of
the cell-adhesive ECM glycoproteins laminin (Liesi et al., 1984; Liesi and Silver, 1988) and
fibronectin (Tomaselli et al., 1986; Biran et al., 2003; Tom et al., 2004) such as the ECM-
related cell surface molecules N-cadherin (Neugebauer et al., 1988; Tomaselli et al., 1988) and
NCAM (Neugebauer et al., 1988; Smith et al., 1990) have been suggested to play a role in
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astrocyte-mediated axonal growth during development and in regeneration. Several in vitro
studies clearly demonstrated that tissue cultured astrocytes are capable of expressing laminin
matrices that support neurite regeneration (Garcia-Abreu et al., 1995; Martinez and Gomes,
2002). Since the strong influence of the ECM component laminin, on axonal growth and regen-
eration is well established (Manthorpe et al., 1983; Luckenbill-Edds, 1997; Freire et al., 2004),
PLL/laminin substrate coating was chosen as a positive control substrate for the experiments.
It has been shown in many studies that laminin as substrate is not an inert surface, but a ma-
jor ECM molecule to promote strong neuronal regeneration in vitro (Liesi et al., 1984; Jones
et al., 2003a; Tucker et al., 2005a,b). Therefore, it is very likely that the overall strong neurite
outgrowth (and length of the longest neurite) observed when exposed to hNP-AC conditioned
media, was influenced by the PLL/laminin substrate.
When neurite outgrowth over hNP-AC ECM was compared to our previously published data,
it was surprising that the preserved ECM supported similar extent of DRG neurite regenera-
tion as was supported by the viable cell monolayers (Fig. 7.1A, compare 2nd and 5th column;
Fu¨hrmann et al., 2010b). Interestingly, the length of the longest neurite sprouting away from
the cell soma was significantly higher on hNP-AC ECM than on monolayers of hNP-AC (Fig.
7.1B, compare 2nd and 5th column, p < 0.001). This observation may be related to observa-
tions by other groups where a morphololgical heterogeneity of astrocytic monolayers has been
reported: astrocytes formed either ”flat” or ”rocky” surface appearances, reflecting the absence
or presence of bumps on the monolayer surface (Grierson et al., 1990; Meiners et al., 1995).
The uneven surfaces were reported to be less permissive for neurite extension than the flat sur-
faces. A more recent finding confirmed this observation, where differences in the neuritogenic
potential of distinct embryonic astrocyte monolayers correlated with the polygonal shaped mesh
of laminin that had been secreted by the glial cells (Freire et al., 2004). It may be suggested
that surface morphologies of the hNP-AC monolayers in the present investigation (see chapter
6.1, Fig. 6.1A) presented a more uneven surface than that provided by the hNP-AC ECM alone.
However, this possibility remains speculative.
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Figure 7.1: Relative neurite outgrowth and longest neurite length for regenerating DRG neurons on cell
culture monolayers compared to the experimental conditions performed in this study.
Graph A is identical to Figure 6.7 in chapter 6.4 and gives an overview about relative overall neurite
outgrowth, except for the first three columns: These demonstrate previous results of our group, which
show neurite outgrowth on monolayer cultures of hMSC and hNP-AC. Data were kindly provided by
T.Fu¨hrmann and K.Montzka.
Graph B shows results for investigation of relative longest neurite length of DRG neurons grown on
monolayers (1st to 3rd column), ECM (4th to 6th column), conditioned media (7th to 9th column) and
combination of ECM with conditioned media (10th to 12th column) of hMSC and hNP-AC.
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In contrast to hNP-AC ECM, the hMSC ECM was found to be a relatively poor substrate for
axon regeneration. Although hMSC-ECM and the defined DRG medium were able to support
neurite outgrowth, the overall length of the regenerating neurites was significantly less extensive
than that supported by the viable hMSC monolayer. This difference was even more prominent
in comparison to the PLL/laminin positive control substrate (Fig. 7.1A, compare 3rd , 4th, 5th
and 6th column, p < 0.001).
Although hMSC ECM seemed to be a relatively poor substrate for axon regeneration, a related
investigation by our group revealed that its orientational cues were, to some extent, responsible
for influencing the direction of neurite outgrowth. The most profound degree of neurite direct-
ionality was supported by viable hMSC and hMSC ECM (Fu¨hrmann et al., 2010a). One pos-
sible explanation for the relatively poor support of neurite outgrowth over hMSC-ECM might
relate to the extent of preservation of the ECM in the present study. It was assumed at the out-
set of the experiment that the ECM from hNP-AC and hMSC would be similarly preserved by
the cell lysis protocol, however, it cannot be excluded that hMSC-ECM may have been poorly
preserved. Thus, a systematic methodological error could have resulted in the observed poor
neurite regeneration. Although in the present investigation there was no attempt to demonstrate
the presence of the residual ECM following the water lysis protocol, this explanation remains
unlikely, since the technique is already well tried and has been tested for numerous cell types
(Lider et al., 1995; Doss, 1999; Milner and Campbell, 2002).
If there is no systematic error in the present experimental model, the results might imply that
hMSC-ECM, alone, enables adherence of DRG neurons, but provides a relatively poor sub-
strate for neurite extension. It has been reported, that hMSC express abundant levels of the
intercellular adhesion- and ECM-related molecules such as N-cadherin, collagen I, collagen IV,
fibronectin and laminin (Puch et al., 2001; Grayson et al., 2004; Schieker et al., 2007). How-
ever, it has been shown that laminin is a better neurite growth promoting ECM molecule than
fibronection for a range of PNS and CNS neurons (Manthorpe et al., 1983; Luckenbill-Edds,
1997; Hynds and Snow, 2001), what might explain the significantly longer neurite outgrowth
on purified laminin coating as substrate than on hMSC-ECM (Fig. 7.1A and B, compare 4th
and 6th column, p < 0.001).
The present data clearly suggest that hMSC-derived molecules, present in conditioned medium,
promote extensive neurite outgrowth. This is in contrast to Kamishina and colleagues who
report the production of ECM components such as fibronectin and laminin to be the prime at-
tributes of canine MSC’s ability to promote neurite outgrowth (Kamishina et al., 2009). This
would suggest the existence of species-dependent variability in the axon growth-promoting
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properties of MSC.
The viable hMSC supported neurite outgrowth that was significantly greater than that observed
over the hMSC-ECM (Fig. 7.1A and B, compare 3rd and 6th column, p< 0.001). Furthermore,
the hMSC conditioned medium promoted significantly greater outgrowth over the PLL/laminin
substrate than was supported by PLL/laminin and DRGM or by hMSC-ECM and DRGM (Fig.
7.1A and B, compare 6th, 7th and 9th column, p < 0.001). This indicates that hMSC sup-
port strong axonal growth by secreted, diffusible substances and confirms observations of oth-
ers, who have suggested the beneficial effects of donor hMSC in SCI to be due to the release
of growth factors and cytokines (Neuhuber et al., 2005; Himes et al., 2006). Furthermore,
real-time-PCR analysis by our group demonstrated that hMSC expressed a range of important
growth factors and neurotrophins, including BDNF, bFGF, EGF, NGF, NT-3, NT-4, VEGF,
SDF-1 as well as cytokines IL-1, IL-6 and IL-8 (Fu¨hrmann et al., 2010a). Neurotrophins are
the most extensively characterised group of extracellular factors that induce axon growth (Zhou
and Snider, 2006), with NGF and NT3 inducing axon growth from sympathetic ganglion cells
and DRG neurons via activation of their corresponding receptors, i.e. tyrosine kinase A and C
(TrkA, TrkC; Snider, 1988; Liebl et al., 1997). Furthermore, BDNF has been shown to be im-
portant for neuronal survival in adult rat DRG neurons (Acheson et al., 1995), whereas VEGF
promoted regeneration through the fetal liver kinase 1 (flk-1) receptor in adult mice DRG (Son-
dell et al., 2000).
It has been suggested that monolayers of hMSC support the generation of a greater number of
primary neurites than monolayers of hNPC, hNP-AC or PLL/laminin substrate (T. Fu¨hrmann,
personal communication). Therefore one may have assumed that an investigation concerning
elaboration of the number of primary neurites over hMSC-ECM, hNP-AC-ECM and PLL/lam-
inin might show similar results. This was, however, not supported by the present study. Despite
the strong induction of primary neurites by viable hMSC monolayers (T. Fu¨hrmann, personal
communication), no such behaviour was observed over hMSC ECM substrate or control sub-
strates that were supported by hMSC conditioned media.
7.5 Interactions of Released Factors with ECM Substrates
The question, to what extent neuronal responses to diffusible trophic factors (i.e. present in
conditioned medium) could be modified by interactions with their substrate environment (i.e.
the ECM) or conversely, to what extent the responses of the cell to its ECM environment were
modified by the presence of diffusible trophic factors was addressed with a combinatorial exper-
imental approach. Two major experimental settings were established, where conditioned media
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and ECM substrate varied: in one experiment hNP-AC ECM was combined with hMSC-M,
and in the other, hMSC-ECM was combined with hNP-AC-M (Fig. 7.1A and B, 11th and
12th column). Overall, the greatest extent of DRG neurite regeneration was supported by hNP-
AC ECM combined with hMSC-M (Fig. 7.1A, 11th column). Outgrowth was significantly
greater compared to outgrowth on hNP-AC ECM with DRGM (Fig. 7.1A, 5th column, p <
0.05), PLL/laminin substrate with hMSC-M (Fig. 7.1A, 9th column, p < 0.05) or the positive
PLL/laminin control with DRGM (Fig 7.1A, 1st column, p < 0.001). Likewise there was a
trend for greater neurite outgrowth, when the combination hNP-AC ECM with hMSC-M was
compared to the outgrowth over viable monolayers of hNP-AC, but this failed to reach the
level of statistical significance though (Fig. 7.1A, 2nd column). It seems that the interaction of
hMSC-M with hNP-AC ECM, or the other way around, the interactions of hNP-AC-ECM with
hMSC-M provided a favourable atmosphere for neurite regeneration and regrowth.
Interestingly, hNP-AC-M supported strong neurite regeneration when applied to PLL/laminin
substrate, but not so when applied to hMSC-ECM. The combinatory application of hNP-AC-M
with hMSC-ECM showed significantly less neurite outgrowth in comparison to hNP-AC-M
with PLL/laminin (Fig. 7.1A, compare 10th to 12th column, p < 0.001). There was only a
slight, statistically not significant, tendency for enhanced DRG neurite outgrowth in the com-
binatorial experiment compared to hMSC-ECM with DRGM (Fig. 7.1A, compare 6th to 12th
column). From that it can be deduced that hNP-AC-M was apparently inable to increase DRG
regeneration over the hMSC substrate.
It is well known that neurite outgrowth is influenced by a number of stimuli including diffusible
nerve growth factors and ECM-mediated mechanisms (Tucker et al., 2005b; Zhou and Snider,
2006). Previous studies have demonstrated that conditioned media of hMSC contributed to the
activation of intracellular signalling pathways in neurons and astrocytes: for example rat and
human MSC-conditioned medium promoted the phosphorylation of mitogen-activated protein
kinase (MAPK), extracellular signal-regulated protein kinase (ERK) and of total extracellular
phosphoinositide 3-kinase/serine/threonine kinase (PI3K/Akt) in primary cultures of rat DRG
neurons.
This suggested that MSCs trigger endogenous survival- and growth signaling pathways in neu-
rons through their secreted soluble factors, including BDNF, VEGF, bFGF and CNTF (Gao
et al., 2005b,a; Zhou and Snider, 2006; Isele et al., 2007; Gu et al., 2010). Similarly, it has been
shown that hMSC conditioned media activate these two pathways in post ischemia rat astro-
cytes, thereby contributing to astrocytic cell survival (Gao et al., 2005b,a).
In addition to growth factors, adhesion of regenerating neurons to ECM proteins (including
fibronectin and laminin) via ligation to their integrin receptors also leads to activation of the
MAPK- and ERK pathway thereby stimulating cell proliferation and regrowth (Boudreau and
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Jones, 1999; Danen and Yamada, 2001). It is also known that integrin-activated signalling path-
ways are capable of interacting with diffusible growth factor-activated pathways to promote
enhanced axonal regeneration: it has been reported that growth factor-mediated signalling and
integrin-mediated signalling converge in adult rat DRG neurons and even that integrin signalling
may be required for certain growth factors (e.g. NGF) to promote their effect on neurite exten-
sion and branching (Tucker et al., 2005b). Similarly, cross-talk between signal transduction
pathways for different growth factors (i.e. NGF and insulin like growth factor-1, IGF-1) has
been reported to act synergistically in the promotion of axon growth (Jones et al., 2003b). Re-
cent studies have suggested that both the Src tyrosine kinase and focal adhesion kinase (FAK)
may act together in regulating the down-stream signalling through the activation of PI3K and
Akt kinase that are required for axonal extension (Tucker and Mearow, 2008).
Other groups have reported that the axon growth inhibitory effects of chondroitin sulphate pro-
teoglycans (CSPG), which are located in the ECM, are due to interference with integrin sig-
nalling and that certain growth factors (e.g. NGF) can induce robust axon growth, even over
inhibitory CSPGs (Zhou and Snider, 2006). It may be that hMSC-M contains such factors,
and that these are not present in hNP-AC-M, or that the levels of these factors are higher in
hMSC-M than in hNP-AC-M. Clarification of this point would require further investigation
into the molecular constituents of hMSC- and hNP-AC- conditioned media as well as the com-
ponents of their respective ECM. Furthermore, the signal transduction cascades associated with
the relevant growth factor and ECM molecules would also need to be investigated.
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The investigation confirmed that both, the extracellular environment through which axons grow
and the availability and action of neurotrophic factors play key roles in regulating axonal growth
and regeneration. Furthermore, it was possible to extend the information about interactions
between diffusible, growth factor mediated effects and those brought about by ECM-related
molecules. The present study clearly indicates that:
I) hNP-AC ECM mediated mechanisms and the release of diffusible factors into the
medium were both involved in the potent axon growth promoting effects of hNP-AC in
vitro; suggesting them as a promising cell type for consideration in future tissue engineer-
ing strategies to promote functional repair in animal models of traumatic CNS and spinal
cord injury.
II) There is an, as yet, undefined benefical cross-talk between hMSC-M mediated sig-
nalling and that induced by hNP-AC ECM; the result being enhanced axon-growth.
III) hMSC ECM appears to contain molecules that are detrimental to axon growth.
IV) Comparison of the extent of axon growth supported by viable hMSC (i.e. that sup-
ported by hMSC ECM and diffusible factors) with that supported by hMSC ECM only
suggests that living hMSC release a factor or factors that is/are capable of over-riding the
inhibitory component(s) of the hMSC ECM.
V) The factors released by hNP-AC, although capable of increasing axon growth over
PLL/laminin and hNP-AC ECM substrates, are incapable of over-riding the inhibitory
effects of hMSC-ECM.
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Final Remarks

8 Final Remarks
The present study gives further evidence that hNP-AC and hMSC possess features that justify
their consideration in future cell therapy-based strategies for repair of the injured spinal cord. In
a previous study our group has described the axon growth promoting effects of hMSC-, hNPC
and hNP-AC monolayers in vitro (Fu¨hrmann et al., 2010a,b). We could show that hMSC were
able to direct neurite regeneration. Furthermore, the immature hNP-AC promoted stronger neu-
rite outgrowth than either non-differentiated hNPC or hMSC. To obtain a better understanding
of the mechanisms accounting for strong neurite regeneration in hNP-AC and hMSC, further in
vitro investigations were performed in the present study.
In Part I of this thesis, the hNPC and hNP-AC were characterised and their proliferative activity
was studied in order to define the cellular changes that were induced by differentiation with the
media supplements BMP4 and LIF. The investigation was successful in a number of aspects:
the characterisation confirmed that the differentiated hNP-AC represented a highly enriched cell
population of immature type I astrocytes, with only a few TuJ1+/MAP2ab+ neuronal cells being
found. These immature hNP-AC expressed the stem/progenitor cell related markers nestin (89.2
± 3.8%), SOX2 (88.0 ± 3.6%), musashi (91.8 ± 2.0%), CD133-and nestin mRNA in similar
proportions to the hNPC, as well as elevated levels of S100β (from 17.6 ± 2.1% in hNPC to
79.4 ± 1.7% in hNP-AC), GFAP (from 23.7 ± 2.3% in hNPC to 92.5 ± 3.4% in hNP-AC) and
CD44 (coexpressed in all GFAP+ hNP-AC).
The characterisation of hNPC and the differentiated hNP-AC in this study might contribute to
the optimisation of protocols for the future generation of hNP-AC in regenerative medicine for
CNS diseases and disorders. However, it should be considered that the establishment of exact
reproducible differentiation protocols has limitations due to the heterogeneity of the source and
age of the tissue used to harvest the neural stem/progenitors. Furthermore, in view of limited
availability of foetal donor tissue and ethical concerns, large scale use of this source as a treat-
ment option remains challenging. On the other hand, recent progress in the research of neural
stem/progenitor cell biology has made it possible to routinely expand neural stem cells obtained
from a small amount of foetal CNS tissue in vitro (Svendsen et al., 1999; Wachs et al., 2003).
To realise preliminary clinical studies in patients in the future, high amounts of cellular material
will be essential. Thus, the proliferative activity of the cells remains an important characteristic
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to be observed. In awareness of the limitations, that are present in an in vitro investigation, the
proliferation experiments of this study revealed that the differentiated hNP-AC showed deceler-
ated proliferation kinetics with a DT of 5.1 days (in the morphological assay), i.e. 3.2 days (in
the metabolic assay) in comparison to non-differentiated hNPC with a DT of 3.5 days (in the
morphological assay), i.e. 1.7 days (in the metabolic assay). However, it should be considered
that the investigations concerning proliferation kinetics cannot reveal exact and generally valid
data. In registration of the varying obtained values in dependency of the performed assays, the
determined doubling times represent approximated values.
In part II of this thesis, the axon growth promoting effects of ECM and conditioned media de-
rived from hNP-AC and hMSC were investigated in vitro. The conditioned media of both cell
types promoted strong neurite regeneration, indicating the release of axon growth promoting
substances into the culture media. The ECM derived from hNP-AC supported strong neurite
regeneration whereas that derived from hMSC only promoted poor regeneration.
A better understanding of the molecular mechanisms involved in such behaviour will require
the identification of which ECM- and diffusible components are produced by both cell types
and which signal transduction cascades they are capable of activating. This information will
be important for understanding the beneficial mechanisms of action of donor cells as well as
influencing the final choice of cell type to be used in future regenerative medicine strategies.
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9 Additional Data
9.1 Formula to Calculate DT in the Morphological Assay
DT =
ln2
α
(9.1)
to calculate the Doubling Time (DT ) from all neurosphere in the morphological assay has been
derived from the following differential equation:
∂V
∂ t
= αV (9.2)
That means proliferation (∂V/∂ t) is propotional to the actual Volume (V ), i.e. cell number.
Transformation and integration resulted in
1
V
∂V = α∂ t Integration→
∫ Vt
Vt=0
1
V
∂V =
∫ t
t=0
α∂ t. (9.3)
The integration leads to
ln Vt− ln Vt=0 = ln VtVt=0 = α(t−0) (9.4)
Using common logarithms this equation leads to the exponential function:
Vt =Vt=0eαt (9.5)
Inserting DT the ratio between the volume VDT and the volume Vt=0 becomes two.
VDT =Vt=0 eαDT ⇒ VDTVt=0 = 2 = e
αDT (9.6)
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Using logarithms the equation for the Doubling time becomes
ln2 = αDT ⇒ DT = ln2
α
. (9.7)
This formula enabled a calculation of mean DT including all neurospheres from the morpho-
logical assay.
9.2 Quantification of hNPC and hNP-AC
Table 9.1: Overview of quantified immunocytochemical phenotypes in hNPC and hNP-AC
Markers hNPC [%] hNP-AC [%]
Stem/ Progenitor Cell Markers
Nestin 91.0 ± 3.4 89.2 ± 3.8
SOX2 89.2 ± 2.7 88.0 ± 3.6
Musashi 91.8 ± 2.0 89.2 ± 3.8
Astroglial Markers
Vimentin 96.8 ± 1.1 92.9 ± 3.8
GFAP 23.7 ± 2.3 92.5 ± 3.4
S100β 17.6 ± 2.1 79.4 ± 1.7
CD44 - coexpression in all
GFAP+ hNP-AC
The table summarises the immunocytochemical phenotypes, that were counted in hNPC and differentiated hNP-AC
for stem/ progenitor cell- and astroglial markers. The proportion of cells labeled for immunocytochemical markers
was analysed in cell monolayers, that hat emerged around PLL/laminin plated neurospheres after 24 hours.
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9.3 Overview of RT-PCR
Figure 9.1: Overview of RT-PCR performed in this study.
RT-PCR was performed for hNPC, hNP-AC (and mature astrocytes, mAC) with the stem/progenitor
cell markers nestin and CD133 such as the glial markers GFAP, CD44, S100β and vimentin. The first
four bands show samples of different hNPC culture passages and the next four bands show samples of
different hNP-AC culture passages. The four bands of mature astrocytes (mAC) are not relevant for
this study, but were processed in the same experimental runs as hNPC and hNP-AC. As positive control
the cell lines U373, THP-1 and MCF-7 were used. H2O was used as negative control. On the left of
each row the the number of bp is marked by the Gene-RulerTM 1kb-ladder. The bottom row of DNA
bands shows the internal control with the house keeping gene GAPDH for each sample.
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9.4 Effect of Trophic Factors and ECM on DRG Neurite
Regeneration in Vitro
Table 9.2: Relative and Absolute Values for All Experimental Conditions
experimental condition overall
neurite
outgrowth
longest neu-
rite length
primary
branches
outgrowth
per branch
[µm]/[-]* [µm]/[-]* [-]/[-] [µm]/[-]*
PLL/laminin 3516 ±223 237 ±7.5 4.9 ±0.15 935.8 ±57
+DRGM 1.0 1.0 1.0 1.0
hNP-AC ECM 6137 ±314 296 ±11 5.8 ±0.3 1421 ±121
+DRGM 1.41 ±0.07 1.21 ±0.05 1.02 ±0.05 1.54 ±0.13
hMSC ECM 1226 ±199 160 ±10 3.7 ±0.2 441 ±90
+DRGM 0.34 ±0.06 0.64 ±0.04 1.02 ±0.05 0.40 ±0.08
PLL/laminin 7089 ±335 337 ±13 6.3 ±0.3 1557 ±155
+hNP-AC-M 1.63 ±0.08 1.38 ±0.05 1.11 ±0.05 1.69 ±0.17
PLL/laminin 3765 ±267 248 ±10 5.0 ±0.2 990 ±114
+hMSC-M 1.43 ±0.1 1.13 ±0.05 1.11 ±0.05 1.28 ±0.15
hNP-AC ECM 7545 ±256 330 ±11 7.0 ±0.4 1468 ±155
+hMSC-M 1.74 ±0.08 1.35 ±0.04 1.24 ±0.07 1.60 ±0.17
hMSC ECM 2175 ±161 122 ±9 4.8 ±0.3 453 ±64
+hNP-AC-M 0.5 ±0.04 0.56 ±0.01 1.06 ±0.06 0.78 ±0.8
The data represent means ± SEM of 100 analysed DRG neurons per experimental condition, except for the ex-
perimental positive control (PLL/laminin + DRGM) which includes means ± SEM of 300 DRG neurons. For
statistical anaylsis relative values were used.
* The bold numbers represent the relative values set in ratio to the positive control (PLL/laminin + DRGM).
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